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The amount and the pace of research on human embryonic stem (ES) cells is 
currently going on at an unprecedented rate due to their potential as a limitless source of 
cells for regenerative medicine and cellular repair. The key to utilizing the regenerative 
capability of human ES cells lies in elucidating the mechanisms underlying self-renewal 
and pluripotency, the two defining features of human ES cells.  
We compared in-house human ES cell SAGE libraries with other ES cell, embryonal 
carcinoma (EC) cell, cancer and normal tissue SAGE libraries available in public databases. 
A major ES/EC cluster was identified using Hierarchical Clustering Analysis. Potential 
pluripotency gene markers were identified as such because they shared the same gene 
expression profile with well-known pluripotency markers like POU5F1/LIN28, SOX2 and 
NANOG. A Transchisq algorithm-based clustering method identified gene expression 
patterns upon differentiation of HES3 cells. These patterns were validated by quantitative 
real-time PCR (qRT-PCR) analysis. For the qRT-PCR confirmation, instead of taking two 
extreme data sets such as undifferentiated and a late stage embryoid body, a time series of 
embryoid body stages ranging from 12h to 14 days was profiled. Based on both the SAGE 
data and experimental qRT-PCR data, we proposed TERF1, SOX2, C14ORF115, NANOG 
and LIN28 could be the good pluripotency markers and differentiation marker such as 
DCN, AA853630 and APOC3 could serve better to assess the true state of the pluripotent 
cells, due to their earlier and higher fold change in expression upon differentiation. 
LIN28, one of the four factors sufficient to reprogram adult fibroblast cells into 
induced pluripotent stem (iPS) cells, plays important roles in embryonic development. 
Functional analysis of LIN28’s role in stem cell pluripotency was conducted by siRNA- 
and shRNA-mediated LIN28 knockdown followed by gene expression profiling using 
Illumina microarrays in human embryonal carcinoma (EC) cell line, NCCIT, which was 
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used as alternative model to human ES cells because of its resemblance to human ES cells 
and its convenience for culture. After knockdown, none of the genes involved in 
pluripotency or differentiation showed significant change of expression. A set of genes 
related to various post-transcriptional regulatory steps such as mRNA splicing, 
cytoplasmic polyadenylation, and mRNA stabilization were identified. We proposed that 
LIN28 might act as a master regulator in differentiation and establishment of pluripotency 
by directly modulating genes responsible for pluripotency or by modulating other post-
transcriptional regulators to form a hierarchical post-transcriptional control. A conditional 
LIN28 knockdown stable line was established from NCCIT, which could be a good tool to 
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1.1 Human embryonic stem cells 
1.1.1 Overview and characteristics of human embryonic stem cells 
 
Embryonic stem (ES) cells are isolated from the inner cell mass (ICM) of embryos of 
blastocyst stage (Martin, 1981; Evans and Kaufman, 1981; Thomson et al., 1998; 
Reubinoff et al., 2000). Research on ES cells could be traced back to 1950s with the study 
of germ cell tumors identified as teratocarcinomas. Later, in the 1970s, the embryonal 
carcinoma (EC) cell line was isolated from teratocarcinomas and cultured in vitro 
permanently (Jakob et al., 1973; Gearhart and Mintz, 1974). The pioneering work in 
mouse EC cells paved the way to the derivation of pluripotent cells from the ICM of mouse 
blastocysts, termed embryonic stem (ES) cells, under culture condition of fibroblast feeder 
layers and serum (Martin, 1981). Since then, efforts have been undertaken to establish 
human ES cells. Bongso et al. (1994) first reported the primary cultures of undifferentiated 
cells from the human blastocyst. These cells eventually underwent differentiation or death, 
as they relied on leukemia inhibitory factor (LIF) supplementation of the culture medium 
instead of embryonic feeder cell support.  In 1998, Thomson and co-workers (1998) 
reported the successful establishment of human ES cell line from blastocysts.  
 Pluripotency and self-renewal are the two defining features of ES cells (Fig. 1). Self-
renewal is defined by the ES cells’ capability to proliferate permanently without 
differentiating under culture conditions. Pluripotency refers to the potential which ES cells 
possess to differentiate into all kinds of cell types, basically including three germ layers, 
endoderm (interior stomach lining, gastrointestinal tract, the lungs), mesoderm (muscle, 
bone, blood, urogenital), or ectoderm (epidermal tissues and nervous system). Traditionally, 
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ICM cells were thought to be excluded from the trophectoderm lineage (Beddington and 
Robertson, 1989). However, it was subsequently found that the ICM still possess the 
ability to differentiate into the trophectoderm lineage (Pierce et al., 1988), and mouse ES 
cells can also be differentiated in trophectoderm under certain culture condition (Niwa et 
al., 2005).  Some researchers have redefined pluripotency as the ability to generate all cell 
types including trophectoderm but without the self-organizing ability to develop into a 
whole embryo (Solter, 2006; Niwa, 2007). Although these two characteristics describe 
different aspects of ES cell, they are closely related to each other. For instance, ES cell 
pluripotency is maintained via self-renewal by the prevention of differentiation and the 
promotion of proliferation under proper culture conditions (Niwa, 2007). 
 
       
Figure 1. ES cells’ two defining features: self-renewal and pluripotency. Under certain condition ES cells 
can proliferate permanently. Meanwhile, ES cells possess the potential to differentiate into all cell types 




Because of their unlimited proliferation and capability to contribute to any tissue, 
human ES cells are considered as an unprecedented source of cells for potential therapy for 
a wide range of degenerative diseases (Wobus and Boheler, 2005; Hyslop et al., 2005a). 
After directed differentiation into target functional somatic cells, purification and 
transplantation, ES cells have already been proven to contribute to the recovery from post-
infarction syndrome (Min et al., 2002), Parkinson’s disease (Kim et al., 2002), 
Huntington’s disease (Dinsmore et al., 1996), and diabetes (León-Quinto et al., 2004) in 
animal models.  
 
1.1.2 Regulatory networks and transcription factors in human ES cells 
 
Various signaling pathways appear to be responsible for maintenance of human ES 
cells (Fig. 2). Unlike mouse ES cells, the combination of LIF and bone morphogenetic 
protein (BMP)-4 is not sufficient to maintain human ES cells. On the contrary, BMP-4 
causes their differentiation towards trophectoderm (Xu et al., 2002; Gerami-Naini et al., 
2004; Bai et al., 2010). In contrast to BMP-4, other transforming growth factor (TGF) - β 
family members such as Activin A, TGFβ1 and Nodal appear to promote pluripotency in 
human ES cells, through the activation of Smad 2/3 that subsequently induces the 
expression of Nanog homeobox (NANOG) and POU class 5 homeobox 1 (POU5F1) 
(Vallier et al., 2005; Babaie et al., 2007). For human ES cells, basic fibroblast growth 
factor (bFGF) is an indispensable component (Amit et al., 2000). Recently, Bendall et al. 
(2007) elucidated that pluripotency of human ES cells is dependent on their interplay with 
human-ES-cell-derived fibroblast-like cells (hdFs), involving bFGF and insulin-like 
growth factor-2 (IGF-2) signaling. Activated by IGF pathway, Phosphoinositide-3-kinase 
(PI3K) (Sato et al., 2004; McLean et al., 2007; Hui et al., 2010) and Extracellular signal-
regulated kinase (ERK) (Li et al., 2004; Feng, 2007; Wang et al., 2010) signalings have 
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been proven to be crucial for human ES cells self-renewal. Another important pathway is 
canonical wingless-type MMTV integration site family (WNT) signaling, which is 
sufficient to maintain self-renewal of human ES cells and through its downstream 
components β-Catenin, it can sustain the expression of POU5F1 and NANOG (Sato et al., 
2004; Ogawa et al., 2006). 
Transcription factors play essential roles in the maintenance of pluripotency in 
human ES cells. The best studied is POU5F1, also known as OCT4 or OCT3, which 
encodes a POU domain factor. The balance of POU5F1 expression level is very important 
to the maintenance of pluripotency. When POU5F1 is overexpressed, human ES cells will 
develop into endoderm; nevertheless, when it is lost, human ES cells will be directed into 
trophectoderm and primitive endoderm (Hay et al., 2004; Rodriguez et al., 2007; Babaie et 
al., 2007). SRY (sex determining region Y)-box 2 (SOX2), another important transcription 
factor, is known to cooperate with POU5F1 to form POU5F1-SOX2 complex to activate 
the target genes in a synergistic way (Chew et al., 2005). Knockdown of SOX2 in human 
ES cells resulted in loss of the undifferentiated stem cell state, as indicated by a change in 
cell morphology, reduced expression of key stem cell factors and increased expression of 
trophectoderm markers (Fong et al., 2008). Knockdown of NANOG by small interfering 
RNA (siRNA) can lead human ES cells differentiation towards extraembryonic lineages 
(Hyslop et al., 2005b). Zaehres et al., (2005) using a NANOG RNA interference (RNAi) 
stable line, reported that NANOG had an antagonizing role in endodermal and 
trophectodermal differentiation. Boyer et al. (2005) using chromatin immunoprecipitation 
(ChIP) combined with genome-wide location techniques, showed that POU5F1, SOX2, 
and NANOG shared a large number of target genes in active or inactive status. Based on 
these results, they proposed that these transcription factors form a regulatory circuitry 




Figure 2. Regulatory networks and transcription factors in maintenance of human ES cells. bFGF is an 
essential component in human ES cell culture, which binds to human-ES-cell-derived fibroblast-like cells 
(hdFs) to promote its IGF2 secretion. IGF2 signaling promotes pluripotency through PI3K/ERK pathway. 
Unlike mouse ES cells, BMP appears to inhibit pluripotency by phosphorylating Smad 1/5/8 in human 
counterparts. WNT, TGF β and Activin A are proven to promote OCT4 and NANOG expression. Three core 
transcription factors, OCT4, SOX2, and NANOG share a large number of target genes and form a regulatory 
feedback circuit to maintain pluripotency. 
 
1.1.3 Induced pluripotent stem cells 
 
In 2006, a Japanese group succeeded in generating mouse induced pluripotent stem 
(iPS) cells from mouse fibroblasts (Takahashi and Yamanaka, 2006) using only four 
transcription factors: Pou5f1, Sox2, c - v-myc myelocytomatosis viral Oncogene homolog 
(c-Myc), Kruppel-like factor 4 (gut) (Klf4). These iPS cells are highly similar to ES cells 
in terms of self-renewal and pluripotency, and they are proven to be able to generate all 
cell types (Maherali et al., 2007; Okita et al., 2007). Later, they achieved generation of 
human iPS cells using the same four factors (Takahashi et al., 2007). Meanwhile, another 
group from the U.S. also reported the successful generation of human iPS cells where they 
also used POU5 and SOX2 shared by the previous reprogramming gene panel, but replaced 
MYC and KLF4 with NANOG and LIN28(Yu et al., 2007).  
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Extensive efforts have been taken to improve the reprogramming system. One 
direction is to minimize the gene set to reprogram. Oncogene c-Myc is proven to be 
dispensable for reprogramming for both mouse and human fibroblasts with lower 
efficiency (Nakagawa et al., 2008). The orphan nuclear receptor Esrrb, incorporated with 
Oct4 and Sox2 can accomplish mouse reprogramming (Feng et al., 2009). It has been 
reported that two factors (Oct4 and Klf4 or c-Myc) are sufficient to reprogram mouse 
neuronal progenitors (Kim et al., 2008). Even Oct4 alone can generate iPS cells from adult 
mouse neural stem cells in spite of low efficiency (Kim et al., 2009a). Another direction of 
improvement is to reduce genome integration events related to tumorigenesis. Non-
integrating adenoviral system was employed successfully to generate human iPS cells 
(Zhou and Freed, 2009). Other non-integrating viruses such as Sendai virus (Fusaki et al., 
2009) and Epstein-Barr virus (Yu et al., 2009) are also able to generate human iPS cells 
and the transgenes were lost gradually after reprogramming. A single viral vector carrying 
all four reprogramming factors was used to generate mouse and human iPS cells through 
only one genome integration (Carey et al., 2009). Using piggyback transposon, Kaji et al. 
(2009) induced virus-free iPS cells with subsequent excision of the reprogramming factors. 
Without any virus integration and modification of the target genome, two studies provided 
safer manners to generate iPS cells. Consecutive transfections of RNA were carried out to 
support continuous protein expression of four core reprogramming factors, which resulted 
in iPS cell colonies from human fibroblasts successfully (Yakubov et al., 2010). Delivery 
of recombinant reprogramming proteins has been reported to generate mouse iPS cells too 
(Zhou et al., 2009). All these researches have explored the therapeutic potential of iPS as 






1.1.4 Human embryonal carcinoma cells 
 
Germ cell tumors (GCTs) arise from primordial germ cells (PGCs). Within GCT 
category, seminomas are generally histologically uniform and seem to resemble a 
transformed state of the PGC. Nonseminomatous GCTs, on the other hand, typically 
include teratocarcinomas with EC components, which are considered as the ‘pluripotent’ 
stem cells of these cancers (Sperger et al., 2003). Despite their germ cell origin, EC cells 
share many commonalities with ES cells in various aspects. Like ES cells, EC cells 
proliferate extensively both in vitro and in vivo and have the potential to differentiate into 
cell types from all three germ layers (Andrews et al., 1984a). If injected into the inner cell 
mass of early embryos, EC cells can contribute to generating chimeric mice as well (Mintz 
and Illmensee, 1975). Both cells express the core stemness transcription factors, POU5F1, 
SOX2, and NANOG, controlling the undifferentiated state (Sperger et al., 2003; Boyer et 
al., 2005). Compared to human ES cells, the most significant difference of human EC cells 
is their karyotypical aberration (Wang et al., 1980),  such as acquirement of additional 
copies of chromosome 17 and chromosome 12 (Rodriguez et al., 1993; Skotheim et al., 
2002). 
The tumorogenic potential of human EC cells makes them unusable for future 
regenerative medicine, but they are a good model to study pluripotency and early 
embryonic development (Josephson et al., 2007). Human EC cells have the following 
major advantages: compared to human ES cells, they can grow without the support of 
feeder layers; they are easy to passage; they are resistant to spontaneous differentiation; 
they are widely available without intellectual property restraints and burdensome 
regulations (Josephson et al., 2007). Many pluripotency markers were originally 
discovered as antigens of human EC cells. These markers include stage-specific embryonic 
antigen-3 (SSEA-3) (Shevinsky et al., 1982; Damjanov et al., 1982), SSEA-4 (Kannagi et 
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al., 1983), and tumor rejection antigens (TRA)-1-60 and TRA-1-81 (Andrews et al., 
1984b).  
Based on transcriptome studies, it has been shown that the ES cells and EC cells 
share similar overall gene expression profiles (Sperger et al., 2003; Liu et al., 2006). A 
microarray study using various human ES cell lines and human GCTs highlighted a set of 
565 genes highly expressed in ES cells and EC cells but not in seminomas (Sperger et al., 
2003). This supports the hypothesis that seminomas closely resemble transformed PGCs, 
while EC cells mostly represent a reversion to more ICM- or primitive ectoderm-like cells. 
Similarly, Liu et al. (2006) also showed that EC cells are clustered together with ES cells 
while differentiated EC cells and embryoid bodies (EBs) can be readily distinguished from 
their parent populations.  
 
1.2 Transcriptome studies of human ES cells 
1.2.1 DNA Microarray 
 
DNA microarray is a multiplex detection and characterization technology based on 
DNA and complementary DNA (cDNA) or complementary RNA (cRNA) hybridization. A 
large number of cDNA or oligonucleotides are spotted on membranes, glass surface or 
plastic as unique probes to achieve a high throughput screening. DNA microarray has 
become one of the main platforms for genome wide expression analysis (Schena et al., 
1995; Noordewier and Warren 2001; Holloway et al., 2002).  
DNA microarray has been widely used in exploring human ES cells stemness 
signature. In one of these early studies, 918 genes enriched in undifferentiated human ES 
cell line H1 compared with their non-lineage directed differentiated counterparts were 
identified (Sato et al., 2003). Recently, the Illumina BeadArray microarray platform has 
also been found popular as its advantages include high sensitivity, redundance of technical 
replicates, smaller sample sizes and the ability of running samples simultaneously. Liu et 
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al., (2006) profiled 48 different samples, including human ES cells, EBs differentiated 
from them, karyotypically abnormal human ES cell line BG01V, human fibroblast feeder 
and EC lines using Illumina BeadArray. Another group used BeadArray to study 
transcriptome co-expression map of human ES cells (Li et al., 2006). Among the total 754 
co-expression domains identified from ES and EB expression data, only 18 domains were 
shared by ES and EB, indicating that the co-expression maps were different between them. 
This study initiated the examination of how transcriptional regulation interacts with 
genomic structure and how genes clustered on the same chromosome are co-expressed 
during the ES cells self-renewal and differentiation. 
 
1.2.2 Expressed Sequence Tags Scan  
 
Expressed sequence tags (EST) scan is a technology based on single-pass sequencing 
of cDNAs (Parkinson and Blaxter, 2009; Clifton and Mitreva, 2009). In the beginning of 
human genome project, EST scan was the main method to profile various tissues and 
discover novel transcripts. Two extensive EST analyses of human ES cells were reported 
by Brandenberger et al. (2004a) and Miura et al. (2004). In the former study, 148,453 high 
quality ESTs (32,764 unique transcripts) were obtained, in which 52% of unique 
transcripts could not be mapped to a UniGene transcripts and represented potentially novel 
genes. Human ES cell EST data was also compared with that of three partially 
differentiated cell populations derived from different protocols, thus increasing reliability 
of differentially expressed gene list. A total of 672 differentially expressed genes were 
identified, and of these, 70% were validated to be differentially expressed by qRT-PCR 
(Brandenberger et al., 2004a). This study also highlighted differentially genes in respect of 
important signaling pathways related to stem cell maintenance. While LIF signaling 
components were not detected, all FGF receptors were up-regulated in undifferentiated ES 
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cells. There were also many WNT and nodal homolog (mouse) (NODAL) pathway 
components, both agonists and antagonists in the list, suggesting that they were tightly 
controlled for proper growth and differentiation of human ES cells. In another study, three 
different ES cell lines (H1, H7 and H9) and their 14-D EBs were used to generate EST data, 
to monitor the state of human ES cells derived from different laboratories using 
independent methods and maintained under various culture conditions (Miura et al., 2004). 
In this study, in addition to discovery of novel plupotency genes, pathways such as WNT 
and TGFβ were stressed in the maintenance of pluripotency. 
 
1.2.3 Massively Parallel Signature Sequencing 
 
Massively Parallel Signature Sequencing (MPSS) is comprised of two steps: a) in 
vitro cloning of cDNA fragments tagged by DpnII on microbeads and b) several rounds of 
ligation-based sequencing. Typically, a sequence signature of 17 bp is determined 
representing its corresponding mRNA molecules (Brenner et al., 2000). In each experiment, 
over a million signature sequences can be generated in parallel, reaching sensitivity at a 
level of a few molecules of mRNA per cell. 
Wei et al., (2005) utilised MPSS to study human ES cell transcriptome. In this study, 
two human ES cell lines were compared with one mouse ES cell line. The results showed 
that only a small core set of genes were shared by both types of ES cells compared to 
differentiating EBs, while a large number of differences was observed indicating the cross 
species biological pathway distinctions. They also pointed out that tags containing a double 
palindrome or falling in a repeat region (eg. Human NANOG and RNA exonuclease 1 
homolog (REX1)) could not be detected. Brandenberger and colleagues (2004b) used 
MPSS to identify eleven thousand unique transcripts from pooled H1, H7, and H9 
undifferentiated human ES cells, of which approximately 25% were novel transcripts. The 
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top 200 abundant transcripts constituted 99% of the total number of counts, among which 
there were only three known ES cell markers, namely SOX2, DNA (cytosine-5-)-
mythyltransferase 3 beta (DNMT3B) and OCT4. Most of the top 200 genes were 
ribosomal genes or genes related to protein and nucleic acid synthesis. No expression bias 
of chromosomal regions was observed and genes from both X and Y chromosomes were 
detected. Similar to the findings from EST study (Brandenberger et al., 2004a), 
components of signaling pathways were detected but their inhibitors were also present, 
indicating the role of negative regulation in maintaining the pluripotency state 
(Brandenberger et al., 2004b).  
 
1.2.4 Serial Analysis of Gene Expression 
 
Serial Analysis of Gene Expression (SAGE) is another popular method in 
transcriptome study. Conventional SAGE protocol produces 14-nucleotides tags to 
represent an individual transcript. Like MPSS, SAGE allows quantitative characterization 
of the transcriptome and has advantages over microarray in its ability to identify novel 
splice variants, exons and genes (Velculescu et al., 1995).  
SAGE cannot reach the depth of MPSS data and its standard cloning and sequencing 
are labor-consuming, but MPSS’s high cost and requirement of complex facility prevent 
researchers from smaller labs from choosing it. It has been reported that the SAGE is 26 
times more sensitive than the EST method for the detection of low abundance transcripts 
(Sun et al., 2004). However, in spite of its great sensitivity, SAGE method suffers from 
ambiguity because of its short sequence signature. In one report, about half of the SAGE 
tags could not match any known expressed sequences and more than one third of the 
SAGE tags that mapped to known expressed sequences, had multiple matches (Chen et al., 
2002). Additionally, during the annotation, the short tags require 100% match to the public 
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available reference databases (SAGEmap (Lash et al., 2000) or SAGE Genie (Boon et al., 
2002), making the method more susceptible to single nucleotide polymorphisms (SNP), 
PCR and sequencing errors. All these drawbacks are adversely influencing the power of 
SAGE technology. 
Many efforts have been taken to reduce the ambiguity of SAGE. Using MmeI 
(LongSAGE) or Ecop15I (SuperSAGE) as tagging enzymes instead of BsmFI (SAGE), the 
tag length can be increased to 21 or 27 bp respectively (Saha et al., 2002; Matsumura et al., 
2003). Nevertheless, LongSAGE protocol generates two-nucleotide recessed 5’ ends, 
which are not filled, thus compromising the faithfulness of transcriptome profiling. The 
unpredictability of Ecop15I has also inhibited its application in complex genome like 
human genome. Reverse SAGE (rSAGE) (Yu et al., 1999) or Generation of Longer cDNA 
fragments from SAGE tags for Gene Identification (GLGI) (Chen et al., 1999) have been 
developed to explore the novel genes or the ones with ambiguous tag identity. Another 
strategy called Gene Identification Signature (GIS) has been developed (Ng et al., 2005), 
whereby MmeI cuts 18bp signature pairs from the 5’ and 3’ ends of full length cDNA for 
gene annotation, rather than a single SAGE tag. They demonstrated that 95.2% of 34,815 
single-locus paired-end ditags (PETs) had matches to known transcripts.  
The first SAGE analysis of the human ES cells was conducted in HES3 and HES4 
lines with different genetic and ethnic backgrounds (Richards et al., 2004). The overall 
profiles of HES3 and HES4 showed basic similarity. Most abundant genes were involved 
in DNA repair, stress responses, apoptosis, cell cycle regulation and development. 
Seventy-three ribosomal proteins were more abundant than in normal tissues. The 
differences between HES3 and HES4 were attributed to different gender backgrounds 
amongst other factors. Comparison of the human ES cells SAGE data with the 21 SAGE 
libraries from normal and cancer tissues not only confirmed known ES-specific markers 
like POU5F1, SOX2, NANOG and REX1, but also highlighted some other less well 
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characterized transcription factors including LIN28 and DNMT3B, which were validated 
by subsequent transcriptome studies repeatedly (Brandenberger et al., 2004a; Hirst et al., 
2007; Assou et al., 2007). Moreover, LIN28 recently was proven to be one of four potent 
ES cells factors sufficient to reprogram the somatic cells into pluripotent stem cells (Yu et 
al., 2007). The authors also compared their SAGE data with available mouse ES cell 
SAGE data and concluded that regardless of basic similarities between human and mouse 
ES cells, there were significant differences in their respective regulatory pathways. Hirst et 
al., (2007) reported similar gene expression profiles among nine human ES cell derived 
from different sources, using longSAGE protocol. In this study, they found increased 
expression of transcripts for RNA binding proteins in human ES cells compared to four 
terminally differentiated cells and 52 novel apparently ES-specific tags were extended by 
5’ RACE, the majority of which represented non-coding RNAs. In order to convert 
“orphan” tags into more useful information, Richards et al. (2006) chose rSAGE to convert 
“orphan” tags into more useful information. This study proved that the SNPs had a 
significant impact on the correct assignment of SAGE tags. Furthermore, the rSAGE 
approach was shown to be useful in identification of natural antisense transcripts (NATs), 
novel introns and new splice variants of known transcripts. 
 
1.3 RNA interference in human ES cells 
 
RNA interference (RNAi) is a post-transcriptional gene regulatory mechanism which 
represses the transcript level inside the living cells. RNAi is evolutionarily conserved in a 
wide range of eukaryotes including animals (Siomi and Siomi, 2009). The RNAi reaction 
is initiated by the enzyme Dicer, which cleaves the double-strand RNA (dsRNA) into 21-
25 bps short fragments. One of the two strands of each fragment, known as the guide 
strand, is then incorporated into the RNA-induced silencing complex (RISC). Subsequently, 
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this complex binds to the target mRNAs matched by the guide strand and cleave the 
mRNAs or repress their transcription (Hannon, 2002). The two types of central molecules 
involved in RNAi mechanism are microRNA (miRNA) and small interfering RNA 
(siRNA). Typically, miRNAs are derived from endogenously expressed precursor RNAs 
and they interact with target mRNAs by recognizing their 3’ untranslated region (UTR) 
(Lagos-Quintana et al., 2002). On the other hand, siRNAs are produced from DNA 
templates expressing short hairpin RNAs (shRNAs) (Paddison et al., 2002).  
The specificity and robust efficiency of RNAi on gene expression make it a valuable 
research tool in cell lines and in living organisms (Fig. 3). Compared with other silencing 
methods such as antisense oligonucleotides and ribozymes, RNAi tends to be more 
effective and less toxic (Miyagishi et al., 2003). In order to achieve RNAi, chemically 
synthesized siRNA molecules or a plasmid producing shRNA can be used to transfect cells. 
Usually, RNA polymerase type III promoters such as the U6 small nuclear RNA promoter 
or H1 promoter are used to drive shRNA expression from the template vectors (Paul et al., 
2002; Brummelkamp et al., 2002). Despite being quick, convenient and cost-effective, 
siRNA and shRNA plasmid transfection remain limited because of the transient nature of 
expression and variable transfection efficiencies. To overcome these drawbacks, virus-
based high-efficiency shRNA delivery systems have been developed (Devroe and Silver, 
2002; Xiong et al., 2005). However, constitutive expression of shRNA cannot be used if a 
gene functions during multiple critical development stages. Thus, drug-controllable RNAi 
has also been developed, which allows for conditional knockdown of endogenous genes 
(Szulc et al., 2005; Matthess et al., 2005). 
Page 15 
       
Figure 3. Lentirivirus-mediated shRNA knockdown. Vectors containing shRNA are packaged into 
lentiviral particles, which are then transduced into mammalian cells. Next, the fragments carrying shRNA are 
integrated into the genome of target cells as templates to express shRNAs. After Drosha processing, shRNAs 
are transported into cytoplasm and cleaved into siRNA by Dicer. One strand (guide strand) of the double-
strand siRNA is associated with RISC to either cleave or repress the transcription of target mRNA matched 
by the guide strand. [From Dr. Dan Cojocari’s web page, Department of Medical Biophysics, University of 
Toronto 2010] 
 
The use of RNAi to knockdown the expression of genes suspected to be functionally 
important for maintenance of human ES cells has facilitated efforts aimed at key genes 
involved in self-renewal and pluripotency, including OCT4, NANOG, SOX2, LIN28, Zic 
family member 3 (ZIC3) (Hay et al., 2004; Hyslop et al., 2005b; Lim et al., 2007; 
Rodriguez et al., 2007; Fong et al., 2008). In mouse ES cells, a cDNA-based RNAi library 
has been generated to facilitate high-throughput functional genetic screens (Jian et al., 
2007). The system used a vector with a convergent H1 and U6 dual promoter for the 
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expression of dsRNA from randomly inserted cDNA. Because RNAi-mediated knockdown 
of specific genes in human ES cells promotes their differentiation towards specific lineages, 
it can be a potential genetic tool to obtain desired cell types from human ES cells, which 
can be good sources for cell therapy for degenerative diseases (Rassouli and Matin, 2009).  
 
1.4 LIN28 is an important regulator for pluripotency in human ES cells 
 
LIN28, an RNA binding protein, contains three RNA binding domains: one cold-
shock domain at the N terminus and two CCHC-type zinc finger domains at the C terminus. 
It was originally found to regulate developmental timing in C. elegans (Ambros and 
Horvitz, 1984).  
Consistent with its function in C. elegans, mammalian LIN28 is found to be 
expressed in embryonic muscle, neurons, and epithelia in a stage-specific manner 
(Polesskaya et al., 2007). In addition, LIN28 is specifically expressed in undifferentiated 
ES cells and EC cells and is reduced during differentiation (Richards et al., 2004; 
Polesskaya et al., 2007). Recent achievement of iPS cells, by overexpressing four genes 
containing LIN28, reinforced the notion that LIN28 is a key regulator of pluripotency in 
human ES cells (Yu et al., 2007).  
 
1.4.1 The interaction of LIN28 and microRNA let-7 family is important 
for pluripotency in human ES cells 
 
Earlier, mouse Lin28 was reported to be regulated by microRNA miR-125b (a 
mammalian microRNA homologous to Lin4) post-transcriptionally accompanied by cell 
differentiation (Wu and Belasco, 2005). In C. elegans, Lin4 binds imperfectly to 
complementary sites in the 3'-UTR and inhibits translation of target mRNAs, including 
Lin28, Hbl-1, and Lin14 (Lin et al., 2003), among which Lin14 protein is able to repress 
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the Lin28 translation proceeding after initiation (Seggerson et al., 2002). Thus, Lin28 may 
be regulated by miR-125b directly and indirectly. 
Several recent papers reported that LIN28 represses let-7 microRNA family 
maturation, but the mechanism remains largely unknown. Several studies found that mouse 
Lin28 binds to the terminal loop regions of let-7 precursor pri-let-7 and represses the let-7 
microRNA at the Drosha processing stage (Newman et al., 2008; Piskounova et al., 2008; 
Viswanathan et al., 2008). However, another group demonstrated that Lin28 binds to the 5' 
stem or the loop region of pre-let-7 to block its processing by the Dicer ribonuclease 
(Rybak et al., 2008). Heo et al. (2008) observed that Lin28 promotes the terminal 
uridylation of pre-let-7 in the cytoplasm, which undergoes degradation subsequently. 
Furthermore, two studies identified Zcchc11 as the uridylyl transferase recruited by Lin28, 
responsible for the uridylation of pre-microRNA in human and mouse (Heo et al., 2009; 
Hagan et al., 2009). Heo et al. (2009) also pinpointed a specific tetra-nucleotide RNA 
sequence motif (GGAG) in the terminal loop of pre-let-7 that is essential for recognition by 
LIN28’s CCHC-type zinc finger domains. Thus, LIN28 may be able to interfere with both 
nuclear and cytoplasmic let-7 processing at multiple post-transcriptional levels during let-7 
maturation. 
The repression of mature let-7 by LIN28 is important for pluripotency in human ES 
cells. let-7 family is well studied in C. elegans, where let-7 regulates a set of target genes 
through post-transcriptional repression to control the transition from undifferentiated, 
proliferating stem cell to differentiated, quiescent cells (Büssing et al., 2008). Moreover, 
let-7 was shown to inhibit High-mobility group AT-hook 2 (HMGA2) (Lee and Dutta. 
2008), RAS (Johnson et al., 2005), Myc (Shah, 2005) and cell-cycle genes (Johnson et al., 
2007), all of which play pivotal roles in ES cell renewal. Although LIN28 is one of the 
four genes sufficient to accomplish reprogramming human fibroblast cells into iPS cells, it 
is not indispensable. Another known negative regulator of various let-7 family members, 
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MYC appears to be able to substitute for LIN28 (Lowry et al., 2008; Park et al., 2008), 
which links their reprogramming capability to the repression of let-7.  
LIN28 and let-7 interaction is also suggested to be involved in primordial germ cell 
(PGC) development (West et al., 2009). Modulation of mouse Lin28 expression level 
during ES cell differentiation revealed its role in development of germ cells. Lin28 
influences PGC development through let-7-mediated effects on B lymphocyte induced 
maturation protein 1 (Blimp1), a key regulator of germ-cell commitment (Saitou, 2009). 
LIN28 was also proven to be associated with malignancies through repression of let-7. 
Dangi-Garimella et al. (2009) showed that human LIN28 and let-7 are part of the 
metastasis signaling. Ectopic expression of mouse Lin28 suggested that it contributed to 
the malignant phenotype and moreover, let-7 loop mutant could abrogate such effect of 
Lin28 overexpression, indicating the involvement of let-7 in Lin28 regulation on 
metastasis (Viswanathan et al., 2009).  
 
1.4.2 LIN28 can regulate target genes post-transcriptionally 
 
Besides repressing microRNA processing, Lin28 is also shown to bind target mRNA 
to regulate translation. In one mouse ES cell study, Cyclins A and B and cdk4 mRNAs are 
found in Lin28-containing ribonucleoprotein particles (RNPs), and their protein levels are 
changed in response to alteration of Lin28 expression. Importantly, the author achieved the 
stimulation of translation of reporter genes by vectors containing 3' UTR of cyclin B 
mRNA (Xu et al, 2009). In addition to the key cell cycle regulatory genes, replication-
dependent histone H2a was also identified as a target of Lin28, which underscored the 
importance of coordinated regulation of gene expression by Lin28 to promote proliferation 
(Xu and Huang, 2009). Mouse Lin28 associates with RNAs containing translation 
initiation complexes, in which the translation initiation factor eukaryotic translation 
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initiation factor 3 subunit b (eIF3b) interacts with Lin28 directly (Polesskaya et al., 2007). 
Furthermore, Lin28 binds to Igf2 mRNA and increases the efficiency of its translation 
initiation involving eIF3b, and the process is essential for skeletal myogenesis. Recently, 
Qiu et al. (2010) revealed human LIN28 stimulates OCT4 mRNA translation by recruiting 
RNA helicase A (RHA), a component of translational machinery to facilitate RNP 
remodeling during translation in human ES cells. RHA has been reported to be capable of 
promoting the formation of RNA-induced silencing complexes (RISC), which is linked 
with LIN28’s function in microRNA processing (Robb and Rana, 2007). Thus, LIN28 can 
selectively bind RNA substrates by recognition of binding sites and subsequently recruits 
eIF3b and RHA to regulate initiation and processing of translation of target mRNAs 
respectively. 
 
1.4.3 Overexpression and knockdown studies of LIN28 
 
Modulation of gene expression by overexpression or knockdown has been commonly 
used to explore the target gene’s functions. The first study of LIN28 in human ES cells was 
reported by Darr and Benvenisty (2008). In this study, clones stably overexpressing LIN28 
were created, which formed around one third of the undifferentiated colonies that parental 
cells formed. They found that the decrease in colonality was due to the slower rate in cell 
cycle (higher proportion in G1/G0 stage) and the increased differentiation to extra-
embryonic endoderm. However, knockdown of LIN28 by siRNA didn’t cause change of 
pluripotency status or cell cycle profile. In human EC cell line PA-1, when LIN28 was 
down-regulated using siRNA, a decrease of 65% in cell viability could be observed (Peng 
et al., 2009). The difference may be due to the higher knockdown efficiency in the latter 
study. In mouse ES cells, modulation of Lin28 didn’t cause differentiation, but 
overexpression and knockdown demonstrated that it promoted cell proliferation by 
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facilitating the progression from S to G2/M phase (Xu et al., 2009).  This observation led 
them to discover the post-transcriptional regulation on cell cycle related genes by Lin28. 
Heo et al. (2009) found that knockdown of Lin28 caused lower Oct4 and Nanog mRNA 
during EB formation, which implied the role of Lin28 in differentiation. 
Two studies employed stable transgenic mouse cell lines over-expression Lin28 to 
explore its function during differentiation. Mouse ES cell line overexpressing Lin28 under 
the induction of doxycycline (DOX) was used to form EBs. The overexpression was 
accompanied by increase of primordial germ cells (PGCs) (West et al., 2009). In the 
second study, constitutive expression of Lin28 in mouse P19 EC cells blocked glial 
differentiation but promoted neurogenesis, when cells were grown as aggregates with 
retinoic acid (Balzer et al., 2010). Furthermore, they also developed various stable lines 
overexpressing Lin28 but with mutants in its functional domains. Through the comparison 
with the mutated versions, they discovered that the conserved domains were differentially 
required for the effect of Lin28 on cell fates. 
 
1.4.4 Objective of the current study 
 
The transcriptome of human ES cells is very distinct from the rest of the cell and 
tissue types as revealed by a comparison of the human ES cells with different tissue types. 
We hypothesize that genes responsible for the maintenance of the pluripotent state share a 
common expression pattern and are significantly up-regulated in undifferentiated human 
ES cells. In addition, well-known pluripotency genes, such as POU5F1, SOX2 and 
NANOG, typically exhibit a gradual decrease in their gene expression profiles upon 
differentiation and as such are not really ideal markers for assessment of the differentiation 
status of human ES cells (Bhattacharya et al., 2005). Analysis of expression profile of 
undifferentiated, partially differentiated and differentiated human ES cells will be carried 
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out in this study to identify genes whose expression levels increase or decrease upon 
differentiation. qRT-PCR will be used to verify their expression profiles using EBs 
harvested at different time points. Though these, we aim to identify suitable gene markers 
that could indicate the differentiation status of human ES cells more appropriately. In 
particularly, we would like to uncover gene markers that show a sharp decline in 
expression even at early stages of human ES cell differentiation. 
Reprogramming factor LIN28 appears to be of great importance in maintenance and 
establishment of pluripotency in human ES cells (Richards et al., 2004; Yu et al., 2007; 
Heo et al., 2009; Hagan et al., 2009). However, various studies show that its knockdown 
does not cause differentiation of ES cells directly (Viswanathan et al., 2008; Darr and 
Benvenisty, 2008; Xu and Huang, 2009; Balzer et al., 2010). This study seeks to elucidate 
LIN28’s functional role in human ES cell pluripotency. siRNA- and shRNA-mediated 
LIN28 knockdown will be conducted in human embryonal carcinoma cell line, NCCIT, 
which will be used as an alternative model to human ES cells because of its resemblance to 
human ES cells and its convenience for culture (Sperger et al., 2003; Boyer et al., 2005). 
After the knockdown of LIN28, transcriptome analysis using Illumina DNA microarrays 
will be carried out to identify transcripts that are perturbed by the knockdown, and this will 








Materials and Methods 
 
2.1 Culture of human ES cell line 
2.1.1 Preparation of feeder cells 
 
J28 mouse embryonic fibroblast (MEF) cells were maintained in MEF medium 
which consisted of Dulbecco’s modified Eagle’s medium: high glucose (DMEM) 
supplemented with 10% One Shot™ Fetal Bovine Serum and 1% L-Glutamine (all from 
GIBCO/Invitrogen). Cells were passaged with 0.05% Trypsin/EDTA every 2 to 3 days, 
once confluency was reached. At the 5th passage, MEFs were bulk cultured in T175 flasks, 
harvested and gamma irradiated with a dosage of 3000 rad. Gamma irradiated MEFs were 
spun down and re-suspended in freezing medium which consisted of 90% One Shot™ 
Fetal Bovine Serum (FBS; GIBCO/Invitrogen) and 10% DMSO (sigma). Irradiated MEFs 
were stored in liquid nitrogen. 
 
2.1.2 Maintenance of human ES cells 
 
The human ES cell line, HES3, from ES Cell International, Singapore 
(http://www.escellinternational.com), was cultured on irradiated MEFs in HES media 
[DMEM-F-12 supplemented with 20% knockout serum replacement (KSR), 2 mM non-
essential amino acids (NEAA), 2 mM L-glutamine, and 4 ng/ml basic fibroblast factor 
(bFGF) (all from Invitrogen, Carlsbad, California, USA)]. 
 
2.1.3 Preparation of embryoid bodies 
 
HES3 cell colonies were cultured until confluency, which was around day 6 or 7. 
Differentiated colonies observed under a Leica M28 dissecting microscope (Leica 
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Microsystems GmbH, Wetzler, Germany) were removed by scrapping with a sterile needle. 
Thereafter, the human ES cells were detached by digestion with 0.5 ml collagenase IV (BD 
Biosciences, San Jose, CA, USA) per 35mm dish for 5 min. The cells were then scraped 
off with a sterile plastic cell scraper and pipetted up and down several times to obtain small 
clumps of approximately 100-150 cells. Cell clumps were centrifuged at 600 g for 2 
minutes and resuspended in differentiation medium [Glasgow Minimum Essential Medium 
(Invitrogen) supplemented with 2 mM L-glutamine, 2 mM NEAA, 0.1 mM β-
mercaptoethanol and 10% KSR] and seeded on ultra-low-adherence 6-well plates (Corning, 
NY, USA). Medium was changed every two days and EBs were harvested at 12 h and 1, 3, 
5, 7, and 14 days. 
 
2.2 Culture of NCCIT cell line 
 
The pluripotent EC cell line, NCCIT was obtained from the ATCC (ATCC Number: 
CRL-2073) and maintained in Roswell Park Memorial Institute medium (RPMI 1640; 
GIBCO/Invitrogen) supplemented with 10% FBS (Hyclone/Thermo Fisher Scientific), 2 
mM L-Glutamine and 50 U/ml penicillin / 50 µg/ml streptomycin (GIBCO/Invitrogen). 
Cells were passaged using 0.05% Trypsin EDTA every 3 to 4 days, according to the time 
at which confluency was reached. 
 
2.3 Preparation of shRNA vectors targeting LIN28 
 
Two shRNA target sequences of LIN28 were selected from the RNAi consortium 
(TRC) library database (http://www.broadinstitute.org/rnai/trc). shRNA sequences were 
ordered as individual oligonucleotides (Table 1) and annealed by heating to 95oC for 5 min 
in a heat block, followed by slow cooling to room temperature by leaving on the benchtop. 
Annealed oligonucleotides encoding respective shRNA were cloned into pLVTHM 
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linearized by ClaI and MluI digestion, downstream of the TetO-H1 region (Fig. 4). The 
inserts were validated by NdeI digestion and sequenced using H1 primer: 5’ 
AGGAAGATGGCTGTGAGG 3’. To construct the inducible shRNA vector, the two 
pLVTHM-LIN28 shRNA constructs were cut with MscI-FspI and the inserts containing 
the LTR/SIN were cloned into pLVET-tTR-KRAB (Szulc et al, 2006) plasmid restricted 
with MscI-FspI. The correct clones were validated by MluI digestion. 
 
Figure 4. Construction of lentiviral inducible shRNA vectors targeting LIN28. shRNA insert 
oligonucleotides were designed to have MluI and ClaI sticky overhangs and a diagnostic NdeI restriction 
enzyme site after the terminating TTTTT sequence. The annealed oligonucleotides were first cloned into 
pLVTHM vector linearized by MluI and ClaI digestion. Then the pLVTHM-LIN28 shRNA constructs were 
cut with MscI-FspI and the inserts containing the LTR/SIN were cloned into pLVET-tTR-KRAB vector 




Table 1. Oligonucleotides used in shRNA vector cloning. 
TRC No. Primer Oligonucleotide Accession No. 
TRCN 
0000021803 
LIN28sh1F 5’ CGCGTTGCTACAACTGTGGAGGTCTATTCAAGAGATAGACCTCCACA 
GTTGTAGCATTTTTCATATGAT 3’ NM_024674.4 




LIN28sh2F 5’ CGCGTCATCTGTAAGTGGTTCAACGTTTCAAGAGAACGTTGAACCAC 
TTACAGATGTTTTTCATATGAT 3’ NM_024674.4 
LIN28sh2R 5’ CGATCATATGAAAAACATCTGTAAGTGGTTCAACGTTCTCTTGAAAC 
GTTGAACCACTTACAGATGA 3’ 
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2.4 Transfection and lentivirus transduction of mammalian cells 
2.4.1 Transfection of supercoiled shRNA vectors 
 
A mixture of pLVET-LIN28sh1 and pLVET-LIN28sh2 vectors were used to 
transfect NCCIT cells to obtain synergistic and higher knockdown efficiency. pLVET-tTR-
KRAB, which does not contain any shRNA insert, was used as negative control. NCCIT 
cells were seeded on a 6-well tissue culture plate (Nunc/Thermo Fisher Scientific) at a 
density of 8 X 105 cells per well. Transfection was carried out the next day. The shRNA 
vectors were transfected using the FuGENE HD transfection reagent (Roche) at a ratio of 2 
µg of plasmid : 6 µl of FuGENE HD. DNA was diluted in 100 µl of Opti-MEM® I 
Reduced Serum Medium (Invitrogen). Then FuGENE HD was added into the DNA diluent, 
after which the mixture was incubated for 15 min at room temperature. The transfection 
complex was added to the cells in a drop-wise manner. The transfection was repeated the 
next day and the same procedure was followed as above. Culture medium was changed just 
before transfection and the following day after transfection. DOX (500 ng/ml) induction 
was initiated two days post-transfection.  
 
2.4.2 Transfection of siRNA 
 
siRNA specific to LIN28 (NM_024674) was obtained from Dharmacon (ON-
TARGET plus SMARTpool), which contains a set of four different double-strand siRNA 
oligos. Cy3 labelled negative control RNA (Qiagen) was included as well. Lipofectamine 
RNAiMAX was used as transfection reagent, because it was proven to be more efficient 
than Lipofectamine 2000 and Oligofectamine in delivering siRNA into human ES cells 
(Zhao et al., 2008). NCCIT cells were seeded on the 24-well plate at a density of 2X105 
cells per well. The transfection was performed on the following day using Lipofectamine 
RNAiMAX (Invitrogen) at a ratio of 60 pmol of siRNA pool : 2 µl of transfection reagent. 
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siRNA and Lipofectamine were diluted in 50 µl of Opti-MEM® I Reduced Serum Medium 
(Invitrogen), respectively. The diluted siRNA was combined with the diluted 
Lipofectamine RNAiMAX and was incubated for 20 min at room temperature before 
adding the siRNA-Lipofectamine RNAiMAX complex to the cells in a drop-wise manner. 
The culture medium was changed and the transfection was repeated the next day as above. 
The cells were harvested 48 or 72 hours after the first transfection. 
 
2.4.3 Lentivirus transduction of NCCIT 
 
The conditional shRNA expression lentiviral vector pLVET-tTR-KRAB was chosen. 
This “Tet-On” version vector contained a gene cassette encoding the tetracycline repressor 
(tetR) fused to Kruppel-associated Box gene (KRAB). The pLVET-tTR-KRAB-mediated 
repression of Pol II (EGFP) and Pol III (shRNA) promoters that were juxtaposed to the tet 
operator (tetO) sequences could be reversibly controlled by doxycycline (DOX) 
simultaneously (Szulc et al., 2006). Thus cells that had stably integrated insert from the 
vector construct could be enriched by selection of the EGFP marker. Because it was 
demonstrated that multiple shRNAs targeting different regions of the same gene could 
have synergistic RNAi effect to improve knockdown efficiency (Song et al., 2008), 
lentiviral vectors pLVET-LIN28sh1 and pLVET-LIN28sh2 were mixed at the ratio of 1:1 
and sent to Burnham Institute for Medical Research, Viral Vector Core Facility (La Jolla, 
California, USA) to package into lentiviral particles. One day before transfection, the 
NCCIT cells were seeded on the 96-well tissue culture plate (Nunc) at a density of 25,000 
cells per well. Before transduction, the old medium was replaced by 100 µl fresh medium 
followed by 15 minutes incubation at 37 oC. An aliquot of 100 µl lentiviral particles was 
added into the culture medium to transduce NCCIT cells at a multiplicity of infection 
(MOI) of 4. Polybrene (5 µg/ml) was used to increase the transduction efficiency. The 
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NCCIT cells were incubated with lentiviral particles for 12 hours and then the medium was 
changed. DOX (1 µg/ml) induction was initiated 36 hours post-transduction. 
 
2.4.4 Lentivirus transduction of HES3 
 
To coat the 96-well tissue culture plate (Nunc), BD MatrigelTM hESC-qualified 
Matrix (BD Biosciences) was diluted in pre-chilled DMEM-F-12 (Invitrogen) at a ratio of 
1:100. Incubation on ice for 10 min was carried out and 50 µl of the mixture was added to 
each well. The plate was then incubated at room temperature for 1 hour. The 
undifferentiated HES3 cells were passaged by mechanical cutting and seeded at a density 
of 20,000 cells per well in mTeSR®1 medium (STEMCELL technologies, Vancouver, BC, 
Canada). On the following day, before transduction, old medium was replaced by 100 µl 
fresh mTeSR®1 medium followed by 15 minutes incubation at 37 0C. An aliquot of 100 µl 
lentiviral particles was added into the culture well to transduce HES3 cells at a MOI of 5. 
Polybrene (5 µg/ml) was used to increase the transduction efficiency. The HES3 cells were 
incubated with lentiviral particles for 12 hours and then the medium was changed. DOX (1 
µg/ml) induction was initiated 36 hours post-transduction. 
 
2.5 Fluorescence Activated Cell Sorting (FACS) 
 
For NCCIT cells transfected by shRNA vectors or transduced by lentiviral particles, 
enhanced green fluorescent protein (EGFP)+ or EGFP- cells were enriched by FACS. The 
NCCIT cells were washed once with PBS and incubated with 0.05% Trypsin/EDTA for 3-
5 min at 37 oC. Culture medium was then added to stop digestion. The cell suspension was 
centrifuged at 600 g for 2 minutes to pellet cells. Next, the cells were resuspended in 
NCCIT culture medium at the concentration of around 1 million cells per ml and blasted 
into single cells. Cell sorting was performed using the MoFlo sorter (Beckman Coulter). 
Page 28 
Forward and side-scatter plots were used to exclude dead cells and debris from the 
histogram analysis. Under the 488nm argon laser, the cells with fluorescence signal greater 
than 102 were collected as EGFP positive cells. The NCCIT normal cells were used as 
negative control. The analysis was performed using software Summit V4.5 (Dako 
Colorado, Inc. Fort Collins, CO, USA). 
 
2.6 SAGE data analysis 
2.6.1 SAGE Libraries 
 
The construction of SAGE libraries for undifferentiated HES3 and HES4 was 
described earlier (Richards et al., 2004). Please note that the sequencing of SAGE tags was 
extended to yield 192739 SAGE tags for HES3. Partially differentiated and differentiated 
HES3 SAGE libraries were generated from cells under prolonged high density cultures. 
For these lab generated libraries, SAGE tag extraction was done using the 
SAGE2000 V4.5 software (Invitrogen), where the minimal ditag length were 24bp and 34 
bp for shortSAGE and longSAGE library, respectively. Database was managed with MS 
access and numerical analyses were preformed with MS Excel. Cancer and normal tissue 
and EC cell libraries were downloaded from CGAP (http://cgap.nci.nih.gov/). In addition 
to the four in-house human ES cell libraries mentioned above, nine longSAGE libraries 
(H1P31, H1P54, HES3UD2, HES4UD2, H7, H9UD2, H13, H14 and BGO1) (Hirst et al., 
2007) and one shortSAGE H9UD1 (http://www.transcriptomes.org/) library were also used 








Table 2. SAGE libraries used in this study. 
Tissue of origin  Library name  Tag length(bp)  Library 
Normal     
prostate SAGE_Chen_Normal_Pr 14  GSM685 
colon SAGE_NC2 14  GSM729 
kidney SAGE_Duke_Kidney 14  GSM708 
Breast SAGE_Breast_normal_endothelium_AP_1 14  GSM1475
Brain1 SAGE_Brain_fetal_normal_B_S1 14  GSM1479
Brain2 SAGE_normal_pool(6th) 14  GSM763 
spinal cord SAGE_normal_spinal_cord 14  GSM2386 
bone marrow SAGE_Bone_marrow_normal_B_D01 14  GSM1478
Blood SAGE_Duke_leukocyte 14  GSM709 
lymph node SAGE_Lymph_Node_Normal_B_1 14  GSM1478
heart SAGE_normal_heart 14  GSM1499 
thyroid SAGE_Thyroid_normal_B_001 14  GSM1477
placenta SAGE_Placenta_normal_B_1 14  GSM1475
liver SAGE_normal_liver 14  GSM785 
pancreas SAGE_Pancreas_normal_B_1 14  GSM1477
Cancer line    
pancreas1 SAGE_CAPAN1 14  GSM678 
pancreas2 SAGE_Panc1 14  GSM742 
breast1 SAGE_PTEN 14  GSM741 
breast2 SAGE_lacZ 14  GSM759 
Colon SAGE_RKO 14  GSM747 
Ovary SAGE_A2780-9 14  GSM675 
Prostate SAGE_CPDR_LNCaP-C 14  GSM680 
Cancer tissue    
Prostate SAGE_Chen_Tumor_Pr 14  GSM686 
Ovary SAGE_OVT-8 14  GSM737 
Stomach SAGE_gastric_cancer-G234 14  GSM757 
pancreas SAGE_Panc_96-6252 14  GSM744 
Lung SAGE_Lung_adenocarcinoma_MD_L9 14  GSM1480
Brain1 SAGE_Duke_757 14  GSM693 
Brain2 SAGE_Duke_1273 14  GSM690 
Brain3 SAGE_ependymoma239 14  GSM1497 
Hemangioma SAGE_Hemangioma_146 14  GSM1516 
skin SAGE_Skin_melanoma_B_DB1 14  GSM1475
Huamn ES cell   
HES3UD1  Undifferentiated HES3 Human Embryonic Stem Cells 14  GSM9220
HES4UD1  Undifferentiated HES4 Human Embryonic Stem Cells 14  GSM9221 
H9UD1  SAGE_Embryonic_stem_cell_H9_normal_p38_CL_SHES1 14  GSM4137
BG01  LSAGE_Embryonic_stem_cell_BG01_normal_p20_CL_SHE19 21  GSM3840
H13  LSAGE_Embryonic_stem_cell_H13_normal_p22_CL_SHE15 21  GSM4136
H14  LSAGE_Embryonic_stem_cell_H14_normal_p22_CL_SHE14 21  GSM4136
H1P31  LSAGE_Embryonic_stem_cell_H1_normal_p31_CL_SHE17 21  GSM4136
H1P54  LSAGE_Embryonic_stem_cell_H1_normal_p54_CL_SHE16 21  GSM4136
H7  LSAGE_Embryonic_stem_cell_H7_normal_p33_CL_SHE13 21  GSM4136
H9UD2  LSAGE_Embryonic_stem_cells_H9_normal_p38_CL_SHES2 21  GSM3195
HES3UD2  LSAGE_Embryonic_stem_cell_HES3_normal_p16_CL_SHE10 21  GSM4135
HES4UD2  LSAGE_Embryonic_stem_cell_HES4_normal_p36_CL_SHE11 21  GSM4136
HES3PD  Partially Differentiated HES3 24P Human Embryonic Stem Cells 21  GSM3104
HES3D  Differentiated HES3 18P Human Embryonic Stem Cells 21  GSM3104
Human EC cell     
EC1  LSAGE_Testis_Embryonal_Carcinoma_CL_hs0212 14  GSM3841
EC2  LSAGE_Testis_Embryonal_Carcinoma_CL_hs0213 14  GSM3841
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2.6.2 Pair-wise comparison 
 
Comparison between individual libraries or library pools was carried out. Fold 
difference (FD) was calculated and p values based on Z-test were determined using 
software SAGEstat (Ruijter et al., 2002). The 3’ ends of the 21 bp longSAGE tags were 
truncated in silico to form 14 bp shortSAGE tags and generation of scatter plots were done 
by DiscoverySpace software (Robertson et al., 2007).  
 
2.6.3 Hierarchical Clustering Analysis and Transchisq clustering 
 
LongSAGE tags were first truncated into shortSAGE tags using DiscoverySpace 
software (Robertson et al., 2007), so that they were comparable. The normal, cancer and 
human ES cell libraries were pooled (ES pool), and this was followed by removal of 
singletons. Next, only those SAGE tags that showed a fold difference (FD) > 4 in ES pool 
over normal tissue pool and a p value <0.0001 were chosen. Calculation of p value was 
based on Z-test (Kal et al., 1999). SAGE tags were normalized to tag per million (TPM), 
and for subsequent calculations, values that were ‘0’ were replaced with ‘1’. HCA was 
performed using Genesis (Sturn et al., 2002). The data went though log2 conversion and 
was mean-centred for each gene. Average linkage method and Pearson Correlation matrix 
were selected in the HCA analysis. All annotations of the SAGE tags used in the analysis 
were based on the CGAP database for the best gene for a tag 
(http://cgap.nci.nih.gov/SAGE). 
For Transchisq clustering, three longSAGE human ES cell libraries (HES3UD2, 
HES3PD and HES3D) were converted to shortSAGE tags using DiscoverySpace 
(Robertson et al., 2007) and combined with the HES3UD1 shortSAGE library. The SAGE 
tags were normalized to tag per 200,000 and in order to remove the genes with 
insignificant expression, the ones whose expression was less than 5 in all the libraries were 
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removed. Further, a criterion of choosing SAGE tags which showed a FD > 4 and p value 
< 0.05 in both HES3UD1 versus HES3D as well as HES3UD2 versus HES3D comparisons 
was applied in order to get the final list of SAGE tags for Transchisq clustering. The tool 
for SAGE data analysis using a Transchisq-based approach was downloaded from the 
website: http://genome.dfci.harvard.edu/sager (Cai et al., 2004; Kim et al., 2007).  
 
2.7 Illumina Microarray 
2.7.1 Isolation of total RNA 
 
The microarray experiment was carried out according to the manufacturer’s 
recommendations for the HumanWG-6 v3.0 BeadChips (Illumina, www.illumina.com). 
There were 48,804 unique 50-mer oligonucleotides probes in each array.  For each probe, a 
random number of times of replicates were included (~30 times on average). All the cell 
samples were harvested and rinsed twice with PBS followed by extraction of total RNA 
using RNeasy® Plus Micro Kit (Qiagen) according to the manufacturer’s protocol. Total 
RNA yield was determined using Nanodrop™ 1000 (Thermo Fisher Scientific) while RNA 
integrity was evaluated with Bioanalyzer 2100 (Agilent Technologies). 
 
2.7.2 Synthesis of double-stranded cDNA and amplification of cRNA 
 
The Illumina® TotalPrep RNA Amplification Kit (Ambion) was used for 
amplification of biotin-labelled cRNA. 100 ng of total RNA in 11 µl of nuclease-free water 
was added to the Reverse Transcription Master Mix. Reverse transcription was carried out 
at 42oC for 2 h and subsequently cooled on ice. The Second Strand Master Mix was then 
added to the first strand reaction. Incubation was carried out at 16oC for 2 h and the 
samples were placed on ice. 
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An aliquot of 250 µl of cDNA Binding Buffer was added to the sample and mixed 
thoroughly by pipetting. The mixture was bound to the cDNA Filter Cartridge and washed 
by 500 µl of Wash Buffer. 10 µl of nuclease-free Water preheated to 55oC was applied to 
elute the double-strand cDNA. The IVT Master Mix was then added to the cDNA sample. 
Incubation was carried out at 37oC for 16 h. 
The reaction was stopped with 75 µl of nuclease-free water. A volume of 350 µl of 
cRNA Binding Buffer was added followed by a 250 µl of ethanol (100%) wash and a 650 
µl of Wash Buffer wash. An aliquot of 200 µl of nuclease-free Water preheated to 55oC 
was added to the centre of the filter and incubated at 55oC for 10 min to elute the cRNA 
product. The cRNA was concentrated by vacuum centrifugation until it reached a 
minimum concentration of approximately 150 ng/µl. The concentration of the purified 
cRNA was determined using Nanodrop and the quality was determined by Agilent 
Bioanalyzer 2100.  
 
2.7.3 Hybridization, wash and scan of Illumina microarray 
 
The hybridization, wash and scan of the Illumina beadarray were performed by the 
candidate in the Biopolis Shared Facility. The microarray hybridization was carried out 
using Illumina Hybridization oven (Illumina). Briefly, 1.5 µg of cRNA was resuspended in 
10µl of water and left at room temperature for 10 min to resuspend the cRNA. A volume 
of 20 µl of hybridization buffer was added to each cRNA sample and mixed thoroughly. 
The hybridization cocktail was incubated at 65oC for 5 min and left to cool to room 
temperature. For each HumanWG-6 v3.0 array, 30 µl of the prepared hybridization 
cocktail was loaded into the sample port. The BeadChips were hybridized at 58oC for 16 h, 
with rocker speed set to 5 in the hybridization oven.  
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The hybridization seals were removed from the BeadChips while submerged in the 
Wash E1BC solution at room temperature and placed into the slide rack before incubation 
in the High-Temp Wash Buffer at 55 oC for 10 min. The BeadChips were then undergone 
one Wash E1BC room temperature wash, one 100% ethanol room temperature wash and 
another Wash E1BC room temperature wash. Each BeadChip was individually blocked in 
a wash tray containing 4 ml Block E1 Buffer for 10 min on the rocker at medium speed. 
The BeadChip was transferred to a fresh wash tray containing 2 ml Block E1 buffer and 2 
µl of streptavidin-Cy3 and incubated for 10 min on the rocker at medium speed. After 
hybridization, the BeadChips were washed by Wash E1BC at room temperature. The 
BeadChips were dried by centrifugation at 275 rcf for 4 min at room temperature. The 
arrays were then scanned with the Illumina Beadstation 500GX using the default setting of 
scan factor 1.0 to maintain consistency and to allow comparisons with arrays from 
different runs. 
 
2.7.4 Bioinformatics data analysis of Illumina microarray 
 
Scanned data were retrieved using Genome Studio software v1.1.1 (Illumina) and 
inspected with the quality control parameters. Data was then background corrected using 
Genome Studio. The latest version of the statistical package R (version 2.10.0) was used 
and downloaded from The Comprehensive R Archive Network (CRAN, http://cran.r-
project.org/) and installed. The R script of the lumi package (Du et al., 2008) was used to 
pre-process the BeadStudio background corrected raw data. The Genome Studio 
background corrected raw data in Sample Probe Profile format was used as the input file. 
The input file and the sample information file were loaded into R. Quality control of the 
data was carried out before and after normalization with density plots, signal intensity 
boxplots and pairwise plots implemented with the ‘lumi’ package. The data was then 
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transformed using the variance-stabilizing transformation (VST) method in order to take 
advantage of the large number of technical replicates that are present on each array (Lin et 
al., 2008a).  Quantile normalization was then carried out to reduce variance between arrays 
so that they can be compared. The data was then filtered with detection p value <0.01. 
The VST transformed data was used for Hierarchical Clustering Analysis using 
Genesis (Sturn et al., 2002), in which complete linkage agglomeration and Pearson 
Correlation matrix were selected. To find out differentially expressed genes in each 
subsequent comparison, three replicates were averaged to represent each sample. The 
differential expression was based on the criteria of fold difference and Student’s T-test, 
which were calculated in MS excel. Each selected gene list was analyzed using GO 
Functional Annotation tool of DAVID (http://david.abcc.ncifcrf.gov/) (Huang et al., 2009). 
The p value of significant GO enrichment was calculated based on a modified Fisher Exact 
algorithm (Hosack et al., 2003). 
 
2.8 Quantitative Real-time PCR (qRT-PCR) 
 
The undifferentiated human ES cells as well as cells grown as EBs were harvested at 
the end of the culture period and RNA was isolated using Trizol reagent according to 
manufacturer’s protocol (Invitrogen) followed by DNase I treatment. For the LIN28 
knockdown study in NCCIT cells, the Total RNA was isolated using RNeasy® Plus Micro 
Kit (Qiagen) as above, which contained a step to remove genomic DNA. First strand 
cDNA synthesis was done using Superscript First-strand synthesis system for RT-PCR 
(Invitrogen) as per manufacturer’s instructions.  qRT-PCR reactions were performed using 
SYBR Green PCR mastermix in an ABI 7500 Fast system (Applied Biosystems) with 20ng 
of experimental cDNA per well in 10 µl reaction system. Reactions were performed in 
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technical triplicates and threshold cycle (CT) values were normalized to 18s rRNA or 
GAPDH. The qRT-PCR primers are listed in Table 3. 
 
Table 3. List of primers used in qRT-PCR (SYBR Green Assay). 
Gene Symbol Accession Forward (5'-----3’) Reverse (5'-----3') 
DCN NM_001920.3 AGCAACCCGGTCCAGTACTG GAGCGCACGTAGACACATCTG 
APOC3 NM_000040.1 TGGCTGCCTGAGACCTCAAT AGGAGCTCGCAGGATGGATA 
SULF1 NM_015170.1 AATGCTGCCCATCCACATG CAGAATCATCCACTGACATCAAAGT 
- AA853603 CATGTTCGGTTGGTCAAAGA TTCCTTTGCATTCATCTCTCAA 
MTUS1 NM_001001924.1 CCCAAGAGATCCCCCACAT GCCCGAATTCCTTGGTGACT 
- BF437082 GTTGTTACCTCAAACCTCCTTTCC TCACTGCATCCCAATCCATCT 
TINF2 NM_001099274.1 GCACCACGAACGCCTTTG ATCAGCTCCACCACCACCTT 
TERF1 NM_017489.1 GCGGTGTGCGGATGGTA GTTTCTCTCTGTTTCTGCCATCTG 
PSMC6 NM_002806.2 CCCTAGAGATAAGGCGCTTCAG CGTCGATCTCCTTGTGTTCAAG 
DTYMK NM_012145.2 AAGATGGTGGATGCTTCCAAAA CAGAGAGCACGCGGATGTC 
MTA3 NM_020744.2 ACCACTCGGAGGACCTGTTTT GCTTCAGAGGCTGACCATTCC 
SOX2 NM_003106.2 ACAGCAAATGACAGCTGCAAA TCGGCATCGCGGTTTTT 
GAL NM_015973.3 ACCTGCTGGGCCCACAT GGCCATTCTTGTCGCTGAAT 
MAT2A NM_005911.4 CAACATGAACGGACAGCTCAAC GGAATGTGCCCTCCTCGAT 
C14orf115 NM_018228.2 GACGGTCCATGCTCAATGGT CCAGCCGAGCTCGTCTCA 
ATP5C1 NM_001001973.1 TTGCAGCCGCAATGGAT TTAGTCTCCTGGTGATATCTTTCAAAGT 
MAD2L2 NM_006341.2 CATGGCTGCCCTGATTCC GCGGGCGATCCACACA 
HSPA4 NM_002154.3 TGCCCTATCCAGATCCTGCTA GAGCCATCAGACTGAGGAGTGA 
- DB107220 GCCTGGGAGGCAGTACCA CTTTCCTCTTCAAGCCTTCCTTT 
OIP5 NM_007280.1 TGAGAGGGCGATTGACCAA CCTTCACCACCTGCGTATCC 
SDHB NM_003000.2 CAGGCCTATCGCTGGATGA GCCAGGCGCTCCTCTGT 
ZNF313 NM_018683.3 GACATGATGAATCAGGTGTTGCA CAAGCACGGACTCTGCTCACT 
- BC073896 GGGCGCAGACTGAAGCA CCAGCAACCCCTGAGCTAAA 
KIAA0841 NM_015302.1 GCCTACATCTTGCAGCATGTG GGTGGCCATACCAGAGTAGGTT 
CKAP4 NM_006825.2 GGACTGCTGTGGACAGTTTGG CCAGATTGTTCTCGTTGGTTTCT 
TMEM41B NM_015012.1 AGGCTGTACCCTCAATGCAGTT TGGGCATCAGGCCAAGTC 
HSPA8 NM_006597.3| TGTGGCTTCCTTCGTTATTGG TGCAGGTCCCTTGGACATG 
POU5F1 NM_002701 ACCCACACTGCAGCAGATCA TGGCGCCGGTTACAGAAC 
NANOG NM_024865 TGCTTTAGTTGGTTTAAGTTCAAATG AAGCTGTATATTTACTCATTGAAACAC 
LIN28 NM_024674 TCCTCATACCCACTTTTGGGATA GCCATCATCATTACCCATTGC 
GAPDH NM_002046.3 AGCCACATCGCTCAGACAC GCCCAATACGACCAAATCC 









3.1 SAGE data analysis to search for pluripotency and differentiation 
markers 
3.1.1 Pair-wise comparisons among human ES cell SAGE libraries 
 
A total of 11 longSAGE and 3 shortSAGE human ES cell libraries were used in this 
study. Two shortSAGE libraries (HES3UD1, HES4UD1) and two long libraries (HES3PD, 
HES3D) were constructed within the lab by previous lab members. Nine longSAGE 
libraries (H1P31, H1P54, HES3UD2, HES4UD2, H7, H9, H13, H14 and BGO1) (Hirst et 
al., 2007) and one shortSAGE library H9UD2 were downloaded from CGAP 
(http://cgap.nci.nih.gov). 
In order to compare the degree of similarity between different cell lines from 
independent sources, pair-wise comparisons were carried out: HES3UD1 vs HES4UD1 
(Fig. 5A); HES3UD2 vs HES4UD2 (Fig. 5B); HES3UD1 vs HES3UD2 (Fig. 5C) and 
HES4UD1 vs HES4UD2 (Fig. 5D). The SAGE tags, with a confidence value greater than 
95% based on the Audic Claverie formula, were considered as differentially expressed 
(light blue dots) (Robertson et al., 2007). HES3 and HES4, either from our lab (Fig. 5A) or 
from Hirst’s lab (Fig. 5B), demonstrated good correlation with each other, with 2.78% and 
2.49% differentially expressed SAGE tags respectively. Comparison of the same cell line 
from different labs showed more genes differentially expressed. 4.03% of SAGE tags in 
HES3 comparison (Fig. 5C) and 4.97% of SAGE tags in HES4 comparison (Fig. 5D) were 
differentially expressed, which might be due to the different culture conditions or library 
construction procedures (shortSAGE vs longSAGE). To rule out the possibility of different 
pluripotency status of cells cultured in two labs, HES3UD1 and HES3UD2 were probed 
for the presence of 95 pluripotency genes common to > 8 experiments and 75 
differentiation genes common to > 6 studies reported in the human ES cell transcriptome 
Page 37 
meta-analysis (Assou et al., 2007). The HES3UD1 and HES3UD2 showed an overlap of 
66 and 81 genes to the pluripotency dataset while 31 and 46 to the differentiation dataset, 
in which the difference could be due to the depth of the analysis in each case. In all four 
comparisons, the majority of the SAGE tags (>95%) were well correlated and the libraries 
from different labs also showed parallel pluripotency status. Thus SAGE libraries from 
different cell lines and independent sources were comparable.   
            
 
Figure 5. Comparisons of different SAGE libraries using DiscoverySpace software. Comparisons of 
HES3UD1 vs HES4UD1 (A); HES3UD2 vs HES4UD2 (B); HES3UD1 vs HES3UD2 (C) and HES4UD1 vs 
HES4UD2 (D). Each dot represented one SAGE tag. The light blue dots represented differentially expressed 
SAGE tags and the dark blue dots represented tags with good correlation. The selection of differentially 









3.1.2 Hierarchical Cluster Analysis of SAGE data 
 
The human ES cells were supposedly very distinct from the rest of the cell and tissue 
types and the molecular basis of this might be defined by a comparison of the human ES 
cells transcriptome with different tissue types. We hypothesized that the genes responsible 
for maintenance of pluripotent state would share a common expression pattern and would 
be significantly up-regulated in undifferentiated human ES cells (UD-hESCs). To 
understand the relationship between pluripotency and differentiation genes better, the 14 
human ES cell libraries were pooled to get 2,790,305 SAGE tags. This dataset along with 
the normal tissue pool (1,209,757), the cancer tissue/cell line pool (654,481) and EC line 
pool (1,834,563) corresponded to a total of 354,116 unique SAGE tags. The complete list 
of libraries used in the analysis is available in Table 2 (section 2.6.1). The singletons were 
excluded from the combined pool thus ensuring that genuine SAGE tags with unit 
representation were not eliminated from the analyses. This left us with a total of 186,141 
unique SAGE tags. Because our study focused on searching for human ES cell specific 
genes and differentiation markers, dimension reduction and selection of SAGE tags for 
further analysis was performed based on significant difference in expression in the 
combined human ES cell libraries compared to a pool of normal tissue libraries. Therefore, 
the final dataset of 5,598 unique SAGE tags was obtained for the Hierarchical Cluster 
Analysis (HCA) by applying a fold difference of > 4 in ES pool over normal tissue pool 
and a p value of < 0.0001.  
Genes with comparable expression patterns were clustered together as well as those 
from similar experiments. Fig. 6 gave the results of HCA of gene expression data. The 
relationship between the different tissues/cell lines was presented as a dendrogram in 
Fig.6A. All the 14 human ES cell and 2 human EC cell libraries were clustered together as 
a separate group from the other tissues/cell lines regardless of the differentiation stages, 
Page 39 
which indicated the uniqueness of the human ES cells from the rest of the cells, cancerous 
or normal and that human EC cells shared a common core set of pluripotency genes with 
human ES cells. In the ES/EC cluster, the differentiated library was separated from the 
others. The rest of the human ES cell libraries could be divided into longSAGE (the 
partially differentiated and nine undifferentiated ES longSAGE libraries) and shortSAGE 
libraries (H9UD1, HES3UD1 and HES4UD1 shortSAGE libraries). Among the non-
pluripotent libraries, the majority of the cancer libraries formed a distinct cluster and the 
second distinct cluster was defined by the presence of a majority of normal libraries.  
Clustering of genes also resulted in distinct groups sharing similar patterns of 
expression across the different libraries. Gene clusters showing enhanced expression in the 
human ES/EC libraries were selected for further analysis. Since POU5F1, SOX2, NANOG 
and LIN28 were key regulators for human ES cells, genes sharing expression patterns with 
them probably formed good candidates for pluripotency related genes. Indeed many of the 
previously described stemness candidates like GAL, ZFP42, ZSCAN10, DPPA4 
(FLJ10713), DNMT3B, HESRG, TDGF1 and ZIC3 shared the clusters with them (Fig. 6C) 
(Sato et al., 2003; Sperger et al., 2003; Brandenberger et al., 2004a; Richards et al., 2004; 
Hirst et al., 2007; Assou et al., 2007; International Stem Cell Initiative et al., 2007). This 
indicated the overall similarity among all the human ES and EC cell lines despite their 
origin.  
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Figure 6. Hierarchical Cluster Analysis of human ES/EC libraries with normal and cancer tissue/cell 
lines. Normalized expression values of 5,598 SAGE tags were visualized, which were selected based on 
differential expression in combined human ES cell libraries compared to pooled normal tissue libraries. 
Clustering was performed using Genesis with average linkage method and Pearson Correlation matrix, after 
log2 and mean centred adjustment among each gene. A. Sample tree showing hierarchy in the relationship of 
tissues and cell lines with human ES cells. B. Entire cluster image labelled by the name of representative 
members. C. SOX2, NANOG, and POU5F1/LIN28 clusters were shown in detail. * indicated that the gene 
was represented by internal SAGE tag. 
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Previous study has shown that POU5F1, SOX2 and NANOG were the key 
transcription regulators involved in maintaining the pluripotent state (Boyer et al., 2005). 
To address the question whether the shared expression profile with the three transcription 
factors was due to the transcriptional regulation by them, the gene list in POU5F1/LIN28, 
SOX2 and NANOG sub-clusters was used to probe the universal binding database of the 
three transcription factors (Boyer et al., 2005). Since this binding database only contained 
17,917 annotated human genes, one SAGE tag without mapping and 18 SAGE tags 
mapped to poorly annotated ESTs were removed from our three sub-clusters. A total of 4 
genes repeated in the list due to multiple tags for the same gene, were further removed, 
which resulted in 43 unique genes. Out of the 43 genes, 17 (39.5%) genes at least bound by 
one of transcription factors were listed in Table 4. Other than POU5F1, SOX2 and 
NANOG themselves, there were several genes containing binding sites for all three 
transcription factors, namely DPPA4, TDGF1, BAMBI, ZIC2, IRX2 and ZIC3. Out of the 
six genes, five contained the same binding regions for all three factors. Chromosome 14 
open reading frame 115 (C14ORF115) was co-bound by SOX2 and NANOG, while 
PRKRIP1 was co-bound by POU5F1 and SOX2. PERP, LECT1, ZFP42, CALB1, SALL2 
and Telomeric repeat-binding factor 1 (TERF1) were bound by NANOG only.  
Table 4. List of genes bound by pluripotency transcription factors. Genes clustered together with 
POU5F1/LIN28, SOX2 or NANOG were examined for binding by transcription factor POU5F1, SOX2 or 
NANOG. “─” denoted no binding and the numbers denoted the distance from the nearest transcription start 
site of target genes.  
Gene POU5F1 SOX2 NANOG 
PERP ─ ─ 729 
NANOG 0 0 0 
LECT1 ─ ─ 850 
ZFP42 ─ ─ 2,279 
C14orf115 ─ 0 0 
DPPA4 0 0 0 
CALB1 ─ ─ 3,389 
TDGF1 0 0 0 
POU5F1 1,103 1,103 1,103 
PRKRIP1 0 0 ─ 
BAMBI 425 425 425 
ZIC2 7,510 2,715 7,268 
IRX2 81 844 844 
SALL2 ─ ─ 6,347 
SOX2 3,469 1,115 2,975 
ZIC3 1,607 1,607 1,607 
TERF1 ─ ─ 5,907 
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3.1.3 Transchisq analysis identified gene expression patterns during 
human ES cell differentiation 
 
Although HCA grouped the ES/EC-specific genes together, we did not identify a 
cluster representing differentiation marker. We hypothesized that by looking into the gene 
expression pattern during human ES cell differentiation, we could find out both 
pluripotency and differentiation genes that were down- or up-regulated upon differentiation. 
The clustering method based on Transchisq algorithm was used, because taking expression 
magnitude of SAGE data into account in determining the gene relationship, it showed clear 
advantages over other algorithms (PCAChisq, PoissonC, PearsonC and Eucli) in analysis 
of developing mouse retina SAGE datasets (Kim et al., 2007). A total of four HES3 
libraries representing the undifferentiated (HES3UD1 and HES3UD2), partially 
differentiated (HES3PD) and differentiated states (HES3D) were pooled to get a total of 
78,191 SAGE tags. Of these four libraries, HES3UD1 was a shortSAGE library while the 
other 3 were longSAGE libraries. The longSAGE tags were trimmed into shortSAGE tags 
so that they could be compared. The SAGE tags were further normalized to tag per 
200,000 and only those SAGE tags whose values were > 5 in all the four libraries were 
retained and this gave a dataset containing 11,033 SAGE tags. Because of the limitation of 
Transchisq clustering in large dataset, further selection of the SAGE tags was done by 
applying a fold difference of >4 and p<0.05 in both HES3UD1 vs HES3D and HES3UD2 
vs HES3D comparisons. This selection process gave a list of 2,466 unique SAGE tags 
which was used for the Transchisq analysis to probe into the patterns of gene expression 
upon differentiation (Fig. 7). 
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Figure 7. Transchisq clustering of undifferentiated, partially differentiated and differentiated HES3 
cells. A total of 2,466 genes differentially expressed during HES3 cell differentiation were clustered using a 
Transchisq-based algorithm (http://genome.dfci.harvard.edu/sager). For each tag, the percentage of 
expression in one sample to all four samples added together was ploted. The genes were clustered into 20 
groups, which can be further subcategorized into A (differentiation), B (pluripotency), C (shortSAGE-
specific), D (longSAGE-specific), E (longSAEG UD-specific) and F (no distinct pattern) based on their 
expression patterns. The numbers of SAGE tags in each cluster were given in brackets besides the cluster 
identity.  
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The 2,466 SAGE tags were clustered into 20 clusters, and they could be further 
categorized into 6 groups based on the expression patterns during the process of 
differentiation of human ES cells. The largest group contained 8 clusters, representing the 
differentiation group (A1-A8). The differentiation group comprised 61% of SAGE tags, 
while the second largest group, pluripotency group (B1-B4) accounted for 15%.  Other 
groups included shortSAGE-specific (C1-C4), longSAGE-specific (D1), longSAGE UD-
specific (E1) and no distinct pattern (F1, F2). Many well-known pluripotency markers 
clustered into the pluripotency group, including TDGF1, DPPA4, DNMT3B, TERF1, 
LEFTY1, GAL as well as all four genes used in iPS cell generation, POU5F1, LIN28, 
SOX2 and NANOG (Richards et al., 2004; International Stem Cell Initiative et al., 2007; 
Assou et al., 2007; Yu et al., 2007). In the differentiation group, cluster A1-A4 contained 
SAGE tags that were up-regulated only upon differentiation, while in A5-A7 clusters, up-
regulation of expression was evident in the PD stage, and they potentially represented early 
differentiation markers. Like the pluripotency group, many well-established differentiation 
markers, such as FN1, IGFBP3, SPARC, PAX6, IGF2 and AFP could be found in the 
differentiation group (Bhattacharya et al., 2005; Cai et al., 2006; International Stem Cell 
Initiative et al., 2007; Assou et al., 2007). 
In order to confirm the expression pattern results from the Transchisq Clustering 
Analysis, a list of representative genes were selected from several clusters that were of 
particular interest (Table 5). Cluster A1 which contained 198 SAGE tags was interesting, 
because it showed the most significant increase in expression in HES3D among all the 8 
clusters that were categorized as differentiation group. SAGE tags which showed at least 
30-fold up-regulation in HES3D, and were totally absent from the UD libraries 
(HES3UD1and HES3UD2) were chosen, and 6 SAGE tags were identified. Another 
interesting cluster from the differentiation group was A6 due to its sharp increase of 
expression in the partially differentiated (HES3PD) library. In addition, the expression was 
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maintained to comparable levels in HES3D also. Out of 69 SAGE tags, three without any 
expression in both UD libraries, were chosen to represent A6. In the pluripotency group, 
B1 cluster contained many well known pluripotency genes such as POU5F1 and SOX2. 
The genes within B1 cluster, which showed > 20-fold difference in both UD libraries vs 
HES3D and the expression was absent in HES3D were selected, resulting in 11 genes. In 
B2 cluster, the expression dropped sharply upon differentiation, so the genes whose 
expression was absent in both HES3PD and HES3D libraries were chosen. For the 
shortSAGE specific group (C1-C4), 5 SAGE tags were chosen based on their absence of 
expression in all the longSAGE libraries. Likewise, 3 genes were chosen from each of D1 
and E1 respectively to represent longSAGE-specific and longSAGE UD-specific groups. 
The mapping of all SAGE tags was reconfirmed by searching for the corresponding 
longSAGE tags in HES3 longSAGE libraries and mapping back using longSAGE tags to 
CGAP ((http://cgap.nci.nih.gov/SAGE). Four SAGE tags that could not be mapped to any 
transcript (including EST) and six transcripts that failed to amplify a product in qRT-PCR 
were removed from further analysis. 
 
Table 5. List of genes selected for confirmation of expression pattern.  











































3.1.4 The clustered gene differential expression patterns were confirmed 
by qRT-PCR 
 
The list for qRT-PCR validation included 27 genes chosen from the Transchisq 
clustering and three pluripotency genes (POU5F1, NANOG and Lin28) as positive controls. 
The HES3 EBs harvested at the various time points (12h, 1, 3, 5, 7 and 14 days) and the 
undifferentiated (UD) HES3 cells were used to represent different stages during 
differentiation. The HES3 EBs were prepared by Wang Yue and the qRT-PCR was done 
by Dr. Shubha Vij and Lai Zhenyang.  
The qRT-PCR results were presented in Fig. 8. The expression detected in HES3UD 
was taken as 1, and the expression in the other samples were normalized to HES3UD’s 
expression and reflected as relative expression. All genes from A1 cluster showed 
overwhelmingly high expression in 14-D EBs compared with undifferentiated HES3 cells. 
Particularly, Decorin (DCN) and Apolipoprotein C-III (APOC3) showed increase of over 
5000 and 160-fold change respectively.  In addition, the expression of DCN and EST 
AA853630 went up by 64- and 11-fold in 12h EB, as compared to undifferentiated cells. 
However, three genes (MTUS1, TINF2 and EST BF437082) from A6 cluster showed the 
highest expression in 12h and 1-D EBs. In the pluripotency group, the majority of genes 
from B1 and B2 clusters had the lowest expression in 14-D EB, with the exception of EST 
DB107220. However, many genes showed higher expression in 12h and 1-D EBs instead 
of UD, including PSMC6, DTYMK, MAT2A, ATP5C1, HSPA4, OIP5, SDHB and 
ZNF313. PIP4K2B from C1 (shortSAGE specific group) showed an expression trend 
similar to pluripotency group, with lowest expression in 14-D EB. The expression of genes 
selected from D1 (longSAGE-specific) and E1 (longSAGE UD-specific) also appeared 
similar to pluripotency group. All the three well known pluripotency genes (POU5F1, 
NANOG and LIN28) had typical pluripotency markers expression, except for higher 





Figure 8. qRT-PCR to confirm the expression patterns during differentiation clustered by Transchisq 
clustering. The HES3 EBs were harvested at the various time points (12h, 1, 3, 5, 7 and 14 days) and the 
undifferentiated (UD) HES3 cells were used to represent different stages during differentiation.  18s rRNA 
was used as internal control. For each target gene, the expression detected in HES3UD was taken as 1, and 
the expressions in the other samples were normalized to HES3UD’s expression and reflected as relative 
expression. 
 
3.2 LIN28 knockdown study 
3.2.1 Lin28 transient knockdown in NCCIT 
 
Both shRNA vectors and synthesized double-strand siRNA were used to achieve 
transient LIN28 knockdown in NCCIT cells. NCCIT cells transfected by pLVET LIN28sh 
vectors were visualized 72h post transfection (Fig. 9A, B). No apparent change in cell 
morphology could be seen after LIN28 knockdown. FACS was employed to obtain EGFP+ 
and EGFP- populations. EGFP+ population represented cells which had taken up the 
Page 48 
pLVET plasmids, while EGFP- population represented otherwise under FuGENE HD 
treatment. For cells transfected by both pLVET-LIN28sh1 and pLVET-LIN28sh2, EGFP+ 
cells with signal intensity greater than 102 (R2, 36.5% in Fig. 9C, D) and EGFP- cells were 
collected (R3, 35.4% in Fig. 9C, D). Likewise, for cells transfected by pLVET-tTR-KRAB, 
those with EGFP signal intensity higher than 102 were collected (R2, 38.9% in Fig. 9E, F).  
For siRNA transfection, double-strand siRNA SMARTpool containing four different 
siRNAs targeting distinct regions of LIN28 was used. 48 h or 72 h after transfection, the 
knockdown efficiency at the both time points was more than 85% compared to NTC 
siRNA transfection (Fig. 10). Like shRNA mediated LIN28 knockdown, no morphological 
change could be visualized under microscope. 
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Figure 9. Transient transfection of pLVET LIN28sh vectors into NCCIT cell line. NCCIT cells were 
transfected by pLVET LIN28sh vectors. Cells were visualized under phase contrast (A) and FITC (B) 72 h 
post transfection. Transfected cells were subjected to FACS. Left panel (C) showed the dot plot whereby 
green fluorescence intensity (FL1) was plotted against forward scatter (FSC). Right panel (D) showed the 
histogram of fluorescence intensity of the transfected sample. Both EGFP+ (R2, 36.5%) and EGFP- (R3, 
35.4%) cells were collected. E, F. EGFP+ population (R2, 38.9%) from cells transfected by pLVET-tTR-





3.2.2 Lin28 shRNA conditional stable line construction 
 
Drug inducible gene knockdown allows for conditional expression of endogenous 
genes, which is particularly useful in developmental studies. The transduced cells were 
visualized under phase contrast and FITC 7 days post transduction. Some cells from the 
transduced NCCIT showed EGFP expression (Fig. 11C, D), whereas transduced HES3 
cells didn’t show any EGFP expression (Fig. 11A, B). Two weeks after transduction, the 
transduced NCCIT cells were trypsinized and subjected to FACS. The cell population with 
the fluorescence intensity greater than 102 (R2, 17.4% in Fig. 11E, F) was collected and 
expanded to establish NCCIT LIN28sh inducible stable line. After expansion, the 
established LIN28sh stable line can be validated by the majority (R3, 94.3%) of the cells 
showing EGFP signal higher than 102 (Fig. 11G, H).  
 
Figure 10. siRNA knockdown of LIN28 in 
NCCIT cells. siRNA pool targeting LIN28 and 
NTC were transfected in NCCIT using 
Lipofectamine RNAiMAX. The expression of 
LIN28 was assessed by qRT-PCR 48 h (A) and 
72 h (B) after transfection. The LIN28 
expression level in each LIN28si knockdown 
sample was normalized to NTC siRNA 
transfection. GAPDH was used as internal 
control. 
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Figure 11. pLVET LIN28sh lentivirus transduction on HES3 and NCCIT cells. pLVET LIN28sh 
lentiviral particles was used to transduce HES3 (A, B) and NCCIT (C, D) cells. DOX was added to induce 
EGFP 36 h post transduction. The transduced cells were visualized under phase contrast (A, C) and FITC (B, 
D) 7 days post transduction. Transduced NCCIT cells were trypsinized and sorted based on the intensity of 
EGFP signal. The left panel (E) showed dot-plot where Green fluorescence intensity (FL1) was plotted 
against forward scatter (FSC). Cells with fluorescence intensity > 102 (R2, 17.4%) were collected and 
expanded. The right panel (F) showed histogram of FL1 and the corresponding events counts. G, H. The 
established LIN28sh NCCIT stable line showed that a majority (R3, 94.3%) of the cells were EGFP positive. 
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The LIN28sh stable line also showed a DOX dose-dependent knockdown of LIN28. 
The NCCIT LIN28sh cells were cultured without DOX for 14 days to ensure that DOX 
induction was minimal. Then various concentrations of DOX treatment (0-1,000 ng/ml) for 
5 days were tested to determine the extent of LIN28 gene knockdown, and then analyzed 
using qRT-PCR (Fig. 12A). As expected, LIN28 knockdown was correlated to the 
concentration of DOX. However, it appeared that there was some leaking as in the absence 
of DOX there was a 22% knockdown. At the highest amounts, both 200 ng/ml and 1000 
ng/ml had comparable levels of LIN28 knockdown. We concluded that 200 ng/ml of DOX 
was sufficient and we used this amount for the time course experiment. As expected, 
LIN28 expression deceased with time and reached the knockdown of 80% by Day 5 (Fig. 
12B), with the only exception of Day 2. The cell photos taken at corresponding time points 
demonstrated coordination of EGFP expression and LIN28 knockdown (Fig. 12C-N). 
Consistent with qRT-PCR data, the stable line cultured in the absence of DOX still showed 









Figure 12. Inducibility test on NCCIT LIN28sh stable line. The EGFP+ cells collected by FACS were 
cultured without DOX for 14 days to minimize the induction. Then the cells were subjected to various 
concentrations of DOX for 5 days. A. The LIN28 mRNA levels were tested by qRT-PCR under 0-1,000 
ng/ml of DOX. B. qRT-PCR to test the time-course of LIN28 knockdown from Day 0 to 5 using 200 ng/ml 
DOX. GAPDH was used as internal control and every sample’s expression was normalized to NCCIT. With 
constant 200 ng/ml of DOX, NCCIT LIN28sh stable line cells were visualized under phase contrast (C, E, G, 
I, K, M) or FITC filter (D, F, H, J, L, N). Photos were taken at Day 0-5 (C-N). EGFP expression showed 






3.2.3 Microarray data analysis 
3.2.3.1 Effect of cationic lipid-based transfection reagents on NCCIT 
expression profile 
 
Three cell samples from supercoiled plasmid transfection (LIN28sh EGFP+, 
LIN28sh EGFP- and pLVET EGFP+), two samples from siRNA transfection (LIN28si and 
NTCsi 48h post transfection) and untransfected NCCIT cells were chosen and for each 
sample, three biological replicates were subjected to Illumina HumanWG-6 v3.0 
BeadChips arrays. After raw data pre-processing and removal of insignificant expression 
transcripts using detection p value < 0.01, the transcript list was narrowed down to 17438 
(section 2.7.4). Based on the 17438 transcripts’ expression, the dendrogram indicating the 
relationship among different samples was generated using Hierarchical Clustering Analysis 
(Fig. 13A). Untransfected NCCIT cells were separated from cells transfected with either 
FuGENE HD or lipofectamine RNAiMAX (RNAiMAX), which suggested that the 
transfection reagents had an effect on the cell expression profile. Within the FuGENE HD 
group, EGFP+ cells with or without LIN28 knockdown were clustered together, despite the 
fact that LIN28sh EGFP+ and LIN28sh EGFP- cells were isolated from the same culture 
wells. This phenomenon suggested EGFP expression also had a bearing on expression 
profile as well.  
In order to explore the effect of transfection reagents, each sample was compared 
with untransfected NCCIT cells. Genes with fold change higher than 2 were selected as 
differentially expressed genes. After FuGENE HD treatment, all three samples had 
comparable numbers of differentially expressed genes (Fig. 13B). The majority of the 
genes (1,955) were shared by all three samples. The genes shared only by LIN28sh EGFP+ 
and LIN28sh EGFP- (203) were slightly more than the ones shared only by pLVET 
EGFP+ and LIN28sh EGFP+ (157) or LIN28sh EGFP- (132), which might be due to that 
both LIN28sh samples were from the same culture well. RNAiMAX influenced gene 
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expression more than FuGENE HD did (Fig. 13C). Like FuGENE HD, most of the genes 
were overlapped in comparisons of LIN28si and NTCsi vs untransfected cells. Both 
FuGENE HD and RNAiMAX were cationic lipid-based transfection reagents, and the 
delivery mechanisms were similar. Hence, these shared genes under each reagent treatment 
were further selected to explore commonality between these two reagents. 1,582 genes 
were affected by both reagents (Fig. 13D). The genes unique to RNAiMAX (1,206) were 
more than the ones unique to FuGENE HD (373), which showed slighter influence by 
FuGENE HD.  
 
Figure 13. Expression profile affected by cationic lipid-based transfection reagents. A. Dendrogram 
showing relationships among different samples. Venn diagrams were generated to show the shared genes 
affected by FuGENE HD (B) or RNAiMAX (C). D. Venn diagrams showed a large overlap of affected genes 
by both cationic lipid-based transfection reagents. 
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The common list of 1,582 genes was analyzed using DAVID (Dennis et al., 2003; 
Huang et al., 2009). The gene ontology (GO) terms were ranked by significance of GO 
enrichment, which was denoted by p value and calculated based on a modified Fisher 
Exact algorithm (Hosack et al., 2003). The most enriched GO terms of biological processes 
for the common genes are listed out in Table 6. The most enriched two terms were cellular 
component organization and organelle organization. Two subcategories of cellular 
component organization were of particular interest, which were membrane organization 
(GO:0016044) and endocytosis (GO:0006897) with the gene counts of 32 and 20, 
respectively. Within the endocytosis subcategory, most of the genes were related to 
receptor-mediated endocytosis, such as LDLR, CTTN, AP1S1, IGF2R, ITSN1, MEGF10 
and SH3BP4 (Sirinian et al., 2005; Lynch et al., 2003; Hirst et al., 2001; Waguri et al., 
2006; Xie et al., 2008; Suzuki and Nakayama, 2007; Tosoni et al., 2005). Three terms 
related to cell cycle were cell cycle, cell cycle process and mitotic cell cycle. 23 genes fell 
into the category of induction of apoptosis by extracellular signals.  
 
Table 6. List of top 10 enriched biological process GO terms from common genes affected by both 



















3.2.3.2 Effect of EGFP expression on NCCIT expression profile 
 
LIN28sh EGFP- was grouped separately from both EGFP+ populations (Fig. 13A).  
LIN28sh EGFP- profile was compared with that of LIN28sh EGFP+ and pLVET EGFP+, 
respectively (Fig. 14). Genes, which passed both the fold change > 1.4 and t-test p value < 
0.05 criteria, were selected as differentially expressed genes. 162 genes were changed in 
both EGFP+ samples, which might be due to the EGFP effects. Enriched GO terms for 
these 162 genes are listed out in Table 7. Generally, the most enriched GO terms were 
related to response to stress/stimulus or metabolic process. The top 2 GO terms were 
response to hypoxia/oxygen levels, which indicated the involvement of hypoxia response 
pathway upon EGFP expression. Within 10 genes associated with hypoxia, PRKCQ, 
BNIP3 and MT3 have already been reported to be involved in response to toxic reactive 
oxygen species (ROS), which were produced during the excitation of GFP (Kaminski et al., 
2007; Mazure and Pouyssegur, 2009; You et al., 2002).  
 















3.2.3.3 Effect of transient LIN28 knockdown on gene expression profile of 
NCCIT 
 
Vectors carrying shRNA and synthesized siRNA were employed to knockdown 
endogenous LIN28 in NCCIT. To study the change of gene expression after knockdown, 
LIN28sh EGFP+ was compared with pLVET EGFP+, while LIN28si was compared with 
NTCsi, so that the impact from cationic lipid-based reagent and EGFP could be removed. 
Genes with fold change > 1.4 and t test p value < 0.05 were considered as differentially 
expressed. LIN28sh caused 138 genes differentially expressed, twice as the ones after 
LIN28si knockdown (Fig. 15). However, no gene was shared by the two comparisons with 




Both gene lists were subjected to GO analysis, where LIN28sh got 115 DAVID ID 
hits and LIN28si got 56. The changed genes with the highest enrichment after LIN28sh 
Figure 14. Venn diagram showing the 
genes commonly affected by EGFP 
expression. LIN28sh EGFP+ and pLVET 
EGFP+ were compared with LIN28 
EGFP- separately. 162 genes changed in 
both comparisons were regarded as 
affected by EGFP expression. 
Figure 15. Venn diagram showing the gene 
affected by LIN28 knockdown. LIN28sh 
EGFP+ was compared with pLVET EGPF+ 
(LIN28sh), while LIN28si was compared 
with NTCsi (LIN28si). Only LIN28 itself 
was shared by the two different ways of 
knockdown. 
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knockdown were related to cellular metabolic processes and transcription regulation (Table 
8). Among other metabolic processes, RNA metabolic process was of particular interest, 
because LIN28 is an RNA binding protein, and plays a pivotal role in both mRNA and 
microRNA metabolism, specifically, post-transcriptional regulation. Other than LIN28, 
there were 8 genes under RNA processing (GO: 0006396) subcategory, which comprised a 
large portion of RNA post-transcriptional regulation. Correspondingly, there were 9 genes 
encoding RNA binding proteins (RBPs) in the GO molecular function analysis. RBPs refer 
to the proteins with one or multiple RNA-binging domains, which usually associate with 
RNA in a sequence- or structure-dependent manner to form ribonucleoprotein particles 
(RNPs). RBPs are essential players in regulation of RNA splicing, localization, 
surveillance, decay and translation (Kim et al., 2009b).  
Nevertheless, the genes whose expression levels changed after LIN28si knockdown 
were not significantly enriched in any interesting biological process. Only one GO term 
(GO:0006886 intracellular protein transport) with 6 genes had an p value (0.0084) for 
enrichment  significance smaller than 0.01. Because Qiu et al. (2009) has pointed out that 
95% knockdown sufficed to observe the Oct4 protein decrease and that the failure to 
observe Oct4 protein level reduction in human ES cells and in their previous study in 
mouse ES cells was due to insufficient Lin28 knockdown, the lack of overlap between 
shRNA (95.2% knockdown) and siRNA (73.7% knockdown) results might be due to the 
different knockdown efficiency as well. 
Genes encoding proteins for RNA processing or RBPs are listed out in Table 9. 
Three genes related to RNA processing also encode RBPs. One cis-acting polyadenylation 
element (CPE) binding protein member, CPEB1 was changed in expression, which recruits 
both cytoplasmic poly(A) polymerase GLD2 and poly(A) ribonuclease (PARN) and thus 
regulates the cytoplasmic polyadenylation (Kim and Richter, 2006). Other two genes in 
this category were serine/arginine repetitive matrix 1 (SRRM1) and U2 auxiliary factor 2 
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(U2AF2). Both of them were proven to be involved in mRNA splicing (Imai et al., 1993; 
Dowhan et al., 2005). 
Five genes were related to RNA processing only. The human homolog of yeast pre-
mRNA processing factor 38, PRPF38A and a well-known haematopoietic transcription 
factor, MYB were affected by LIN28 knockdown.  The remaining genes in this category 
included tRNA splicing endonuclease 34 homolog (TSEN34), GTP binding protein 3 
(GTPBP3) and nucleophosmin/nucleoplasmin, 3 (NPM3). 
Six genes encoded proteins with RNA binding property and performed their roles in 
other post-transcriptional regulatory steps than RNA processing. In this list, CSDE1 is a 
cold shock domain containing protein (Grosset et al., 2000). Two genes involved in mRNA 
translation were also affected by LIN28 knockdown, namely UHMK1 and MRPL11 
(Cambray et al., 2009; Voronina et al., 2003). Other genes in this list were PTRF, ZNF74 
and ZMAT3. 
 





































Symbol Human gene name 
Both RNA processessing and RNA binding 
CPEB1 Homo sapiens cytoplasmic polyadenylation element binding protein 1 
RBM39 Homo sapiens RNA binding motif protein 39 
SRRM1 Homo sapiens serine/arginine repetitive matrix 1 
RNA processing only 
PRPF38A Homo sapiens PRP38 pre-mRNA processing factor 38 (yeast) domain containing A 
TSEN34 Homo sapiens tRNA splicing endonuclease 34 homolog (S. cerevisiae) 
MYB Homo sapiens v-myb myeloblastosis viral oncogene homolog (avian) 
GTPBP3 Homo sapiens GTP binding protein 3 (mitochondrial) 
NPM3 Homo sapiens nucleophosmin/nucleoplasmin, 3 
RNA binding only 
PTRF Homo sapiens polymerase I and transcript release factor 
ZNF74 Homo sapiens zinc finger protein 74  
CSDE1 Homo sapiens cold shock domain containing E1, RNA-binding 
ZMAT3 Homo sapiens zinc finger, matrin type 3  
UHMK1 Homo sapiens U2AF homology motif (UHM) kinase 1 





4.1 SAGE data analysis provides robust candidates for stemness 
assessment 
 
Our current understanding of the molecular basis of pluripotency in human ES cells 
stems largely from global transcriptome profilings, including DNA microarray (Sperger et 
al. 2003; Bhattacharya et al., 2004), SAGE (Richards et al., 2004; Hirst et al., 2007), EST 
(Brandenberger et al., 2004a; Miura et al., 2004) and MPSS (Wei et al., 2005). We chose 
SAGE method because of the feasibility to compare SAGE libraries of different tissues and 
cell types across different laboratories and its capability to discover novel transcripts. In 
this study, we analyzed our SAGE libraries with other available SAGE libraries. Most of 
the previous studies compared human ES cells with terminally differentiated cells, whereas 
in order to find out the expression patterns upon differentiation, we incorporated both 
partially differentiated and differentiated human ES cells in our current study. 
 
4.1.1 Hierarchical Cluster Analysis identifies a major ES/EC-specific 
cluster 
 
The in-house constructed SAGE libraries were compared with other human ES/EC 
cell lines as well as normal and cancer tissue libraries available in public databases. HCA 
was performed on the set of genes up- or down-regulated in human ES cell library pool 
compared to normal tissue library pool, which was determined by Z-test and fold 
difference. ES and EC cells showed a close relationship in the dendrogram. Several studies 
have compared the transcriptome profiles between human ES and EC cells. Despite 
differences in expression of germ cell markers in EC cells, overall similarity was observed 
in one such study that employed Illumina BeadArray to profile both mRNA and miRNA 
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expression in human ES lines (H1, H7, H9 and BG03) and EC lines (2102Ep and NTERA-
2) (Josephson et al., 2007). Like our results, Liu et al., (2006) also found that human EC 
cells were closer to human ES cells while the differentiated EBs could be readily 
distinguished from them. The genes were also clustered based on the similarity of their 
expression. A major ES/EC specific cluster was the most distinct and included the 
NANOG, POU5F1/LIN28 and SOX2 sub-clusters. Another cDNA microarray study 
included human ES cells, germ cell tumors, somatic cell lines and testicular tissue samples 
(Sperger et al., 2003). Using HCA, they found a cluster shared by ES, EC and seminoma in 
addition to the ES/EC cluster. Due to the lack of seminoma SAGE library, we could not 
identify such cluster. 
Within the NANOG, POU5F1/LIN28 and SOX2 sub-clusters, besides some well 
established stemness genes, many novel genes also showed up. Some of them could be 
good candidates of pluripotency regulators. For instance, PERP, a tetraspan 
transmembrane protein, is an effector of p53.  It plays a role in the p53-mediated apoptosis 
and when overexpressed in p53-/- MEF cells, it induces programmed cell death (Attardi et 
al., 2000). The balance between cell proliferation and the inhibition of apoptosis as well as 
differentiation is required for the self-renewal in undifferentiated ES cells (Sumi et al., 
2007; Duval et al., 2006). Thus PERP may be involved in the regulation of such balance. 
BAMBI encodes a transmembrane glycoprotein. As a pseudoreceptor, it has a conserved 
function in regulation of TGFβ signaling in frog, mouse, zebrafish and human (Yan et al., 
2009). In addition, it has been reported to positively modulate Wnt/β-Catenin signaling 
(Lin et al., 2008b). Both signaling pathways are essential to maintain human ES cell 
pluripotency (Babaie et al., 2007; Ogawa et al., 2006). Another interesting gene, SALL2, 
is one of the four human homologs (SALL1 to SALL4) to the Drosophila homeotic gene 
spalt (sal), which is important throughout the entire Drosophila embryonic development 
(Böhm et al., 2008). One spalt family member, Sall4, contributes to the maintenance of 
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mouse ES cells and early embryonic development through the transcriptional regulation by 
Pou5f1 (Zhang et al., 2006), which sheds light on the importance of Sall family in ES cells. 
PLK4 gene encodes a member of the polo family of serine/threonine protein kinases, 
which is known to promote centriole duplication during the cell cycle (Kleylein-Sohn et al., 
2007). More importantly, it is able to phosphorylate Hand1 and help the nucleo-release of 
Hand1 which subsequently acts to promote an exit from the mitotic cycle and the onset of 
differentiation of mouse trophoblast stem (TS) cells (Tanenbaum et al., 2007).  
 
4.1.2 Genes co-expressed with POU5F1, SOX2 and NANOG possess 
binding sites for these core pluipotency factors 
 
Transcription factors, POU5F1, SOX2 and NANOG, have been reported to 
collaborate to form a regulatory hierarchy to contribute to the maintenance of pluripotency 
and self-renewal (Boyer et al., 2005). The authors found that these three factors regulate 3, 
7 and 9% of the known protein-encoding genes, respectively. However, our data showes 
higher percentage of target genes (23.2%, 25.6% and 32.7%) in POU5F1/LIN28, SOX2 
and NANOG sub-clusters. This result indicates that when HCA clusters genes with 
pluripotency markers based on their expression profile, it also enriches target genes 
regulated by the three transcription factors and that transcriptional regulation is one reason 
for some genes’ shared expression pattern with these transcription factors. Our results also 
show that the regulatory region of many genes contain binding sites for multiple 
transcription factors, which suggests these transcription factors function cooperatively. In 
both human and mouse studies, it has been well established that Pou5f1 and Sox2 are able 
to form a heterodimer on DNA to regulate gene expression synergistically (Ambrosetti et 
al., 1997; Reményi et al., 2004; Chew et al., 2005). Nevertheless, the manner in which 
NANOG interacts with POU5F1 and SOX2 is still unclear. 
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However, it is worthy of note that a great number of genes (60.5%) in these sub-
clusters do not have such binding sites in their promoters, including previously described 
pluripotency markers such as GAL, ZSCAN10, DNMT3B and LIN28 (Richards et al., 
2004; Assou et al., 2007; Wang et al., 2007; Darr and Benvenisty, 2009). Thus, the 
clustering of those genes together with the three transcription factors probably implies that 
these genes themselves can play independent roles in the maintenance of the pluripotency 
transcriptional network. 
 
4.1.3 Transchisq clustering reveals new potential pluripotency and 
differentiation markers based on expression pattern 
 
After Transchisq clustering of HES3 UD, PD and D SAGE data, the genes that 
showed increase or decrease in expression during differentiation were of particular interest. 
Confirmation of the expression patterns was done by monitoring EBs generated from 
human ES cells at different time points using qRT-PCR. Compared to their more 
differentiated progenies, the EBs represent the earliest stage of differentiation in culture, 
which have been employed in some such studies (Cai et al., 2006; Bhattacharya et al., 
2005). These studies have usually used a late stage EB and UD ES cells for comparison but 
our purpose of taking a series of time points is to identify sensitive markers in addition to 
the validation of gene expression patterns during progression of differentiation in human 
ES cells. 
Within the differentiation group, validation was done for representative genes from 
A1 and A6. The best markers of differentiation would be those which exhibit a marked 
increase in expression even at the first stage of differentiation being studied (12h EB in this 
case). Amongst the genes representing the differentiation clusters, the expression of DCN 
and AA853630 were strongly up-regulated in 12h EB compared to HES3 UD and hence 
would serve as promising markers. Other three differentiation genes (MTUS1, EST 
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BF437082 and TINF2) from A6 showed the expected sharp increase in the early stages of 
EB. However, the expression dropped after 12h and 1-D EBs and 14-D EB showed 
comparable levels to UD. One possible explanation could be that the SAGE data was 
derived from PD and D generated by prolonged culture, while qRT-PCR data was 
produced by EBs at different points. The two different methods of differentiation could 
introduce the inconsistency.  
In the pluripotency group, the majority of genes from B1 and B2 demonstrated the 
lowest level of expression in 14-D EB. In one earlier study, 13-D EB was chosen to 
compare with the UD human ES cells using DNA microarray, since at this stage the up-
regulation of differentiation markers and down-regulation of pluripotency markers were 
the most apparent (Bhattacharya et al., 2005). Similar to their findings, we observed that 
most pluripotency genes showed the most evident decline at the 14-D EB stage. They also 
suggested LIN28, PSIP2, PITX2, DNMT3B and GALANIN as good markers, but POU5F1, 
SOX2 and NANOG were not good as their expression levels showed a more gradual 
decrease upon differentiation. In our study, we have identified several differentiation genes 
with a rapid increase in expression even in the first stage of differentiation assessed (12h 
EB). However, such drastic change was never evident in the pluripotency clusters, where 
decrease in gene expression was always gradual. Only C14ORF115 had ~2-fold decrease 
in expression level from UD to the 12h EB stage. Thus, for all pluripotency genes, UD to 
1-D EB transition rather than 12h EB would be a better time frame to choose pluripotency 
markers. Considering these criteria, TERF1, SOX2, C14ORF115, NANOG and LIN28 
could be the markers of choice for assessing the pluripotent status. In conclusion, 
differentiation markers such as DCN, APOC3 and AA853630 could serve as better 
markers to assess the true state of the pluripotent cells, because of their earlier and higher 
fold change of expression upon differentiation. 
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4.2 LIN28 knockdown reveals its role in pluripotency at the post-
transcriptional level 
4.2.1 Cationic lipid-based transfection reagents deliver DNA into cells 
through endocytosis and bring toxicity 
  
Cationic lipid-mediated transfection is widely used to bring membrane-impermeable 
DNA into cells. The basic structure of catinonic lipids consists of a positively charged head 
group and one or two hydrocarbon chains. Together with a neutral helper lipid, catinonic 
lipids are formulated in a unilamellar liposomal structure, which facilitates DNA 
condensation and fusion with the cell membrane (Liu et al., 2003). It should be noted that 
catinonic lipids could influence the lipid metabolism, so it is not suitable for the study of 
biological processes sensitive to lipid levels. For example, amyloidogenic β-amyloid 
precursor protein (AβPP) processing and Aβ production are artefactually affected by cell 
transfection reagents (Romano et al., 2006). 
One previous study explored the effects brought by FuGENE HD and compared 
them to three other commercial transfection reagents (Jacobsen et al., 2009). They found 
all four reagents trigger cellular response to stimulus significantly. However, because they 
used the same vector backbone for transfection, it is hard to tell whether the commonalities 
are due to the common effect by these reagents or the due to the introduction of the foreign 
vector. We used two types of cationic lipid-based transfection reagents, FuGENE HD and 
Lipofectamine RNAiMAX (RNAiMAX), to deliver LIN28shRNA vector and 
LIN28siRNA, respectively. Thus, the differentially expressed genes shared by both 
reagents in our study reflect the true commonalities in these two cationic lipid-based 
reagents. After transfection, genes related to membrane organization and endocytosis were 
affected. Endocytosis is the main process for the cell to uptake the DNA:liposome complex 
through a localized region of the cellular membrane, which is formed by cationic lipids, 
neutral helper lipid and DNA (Stamatatos et al., 1988; Wrobel and Collins, 1995). After 
DNA : liposome complex enters into cytoplasm, disruption of endosomal membrane and 
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breakdown of nuclear membrane are important for the entry of DNA into the nucleus 
(Wattiaux et al., 1997; Mortimer et al., 1999). Our data reflects the activation of the 
process of endocytosis under the treatment of cationic lipid-based reagents. Cell cycle and 
induction of apoptosis were also significantly enriched in the GO analysis. The toxicity of 
cationic liposomes resulted from membrane ruptures and charge neutralization to cells is 
well known (Hirko et al., 2003). Affected cell cycle and induced apoptosis might be the 
consequences of this toxicity. In conclusion, cationic lipid-based reagents deliever DNAs 
through endocytosis during transfection, which may cause side effects such as affected cell 
cycle and induced apoptosis to the target cells and should be paid attention to when 
designing experiments. 
 
4.2.2 EGFP should not be considered as a biologically inert indicator 
 
Green fluorescent protein (GFP) is a single-chain polypeptide of 238 amino acids 
from the jellyfish. GFP and its multiple forms, such as enhanced GFP (EGFP), have been 
widely used as marker proteins or tracking signals in many biological studies (Zimmer, 
2002). Although it was raised that GFP might be toxic and GFP fusion proteins might have 
different intracellular localizations from wild type proteins, it remains amongst the most 
reliable and convenient markers available (Liu et al., 1999; Hanson and Ziegler, 2004).  
We used EGFP to track the cells which had successfully taken up the pLVET or 
LIN28sh supercoiled plasmids during transient transfection. Genes affected by EGFP 
expression were selected for GO analysis. Our data reveals the significance of hypoxia 
response after EGFP expression and activation under UV. Oxygen is known as the key 
molecule in the mechanism of activation of the fluorophore from ordinary GFP protein 
structure under illumination (Yang et al., 1996). During the excitation of GFP, various 
reactive oxygen species (ROS), such as hydrogen peroxide and singlet oxygen, are 
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produced (Remington, 2006), whose production is usually increased by cellular hypoxia 
and in return triggers downstream hypoxic response signaling (Hamanaka and Chandel, 
2009). In our study, within the category of hypoxia response, several genes have already 
been found to be crucial for ROS production and response. One protein kinase C (PKC) 
family member, PRKCQ, has been suggested to be an essential component to form the 
proximal T-cell receptor-signaling, which is crucial in production of ROS by mitochondrial 
complex I and the subsequent activation-induced T-cell death (Kaminski et al., 2007). Two 
other genes are able to respond to increase of ROS, namely BNIP3 and MT3. BNIP3 
together with other BNIP members is induced by the hypoxia-inducible factor (HIF-1) and 
mediates mitophagy, a metabolic adaptation for survival that is able to control ROS 
production and DNA damage caused by ROS (Mazure and Pouysségur, 2009). MT3, a 
cysteine-rich low molecular weight metal binding protein, protects cells from DNA 
damage, apoptosis and cell death caused by toxic ROS (You et al., 2002; Ren et al., 2001). 
Based on these changes observed by us, we conclude that hypoxic response signaling 
might be an important mechanism to protect cell from damages caused by ROS, which is 
produced during the excitation of GFP. 
Our results showed that the effects of EGFP on the gene expression are related to 
responses to stress/stimulus or metabolism, which is also reported in an earlier study using 
DNA microarray to detect the change of transcriptome profile after GFP expression in 
cardiac myocytes (Badrian and Bogoyevitch, 2007). It is generally accepted that GFP 
induces an immune response in vivo, one of the mechanisms of responding to stimulus 
(Stripecke et al., 1999; Yamamoto et al., 2000). Several publications have found some 
other cellular effects brought by GFP/EGFP expression. For example, GFP expressing 
cells showed higher level of cell contraction, death and apoptosis (Liu et al., 1999). EGFP 
and EGFP fusion proteins affect RING E3 ubiquitin ligase-dependent processes and 
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polyubiquitination (Baens et al., 2006). It has also been proven that GFP can compete with 
actin in binding to myosin and thus disrupt actin-myosin interaction (Agbulut et al., 2007).  
In summary, although effects of GFP on gene expression have not been widely 
acknowledged, it is possible that GFP may affect cellular events through generation of 
toxic ROS, disruption of actin-myosin interaction and proteasomal protein degradation 
(Remington, 2006; Agbulut et al., 2007; Baens et al., 2006). Thus, EGFP should not be 
considered as a biologically inert indicator, but rather the proper control is needed in 
experiments in which EGFP is utilized. 
 
4.2.3LIN28 knockdown does not cause differentiation of pluripotent stem 
cells 
 
LIN28 is expressed specifically in undifferentiated ES and EC cells in both human 
and mouse (Richards, et al., 2004; Lee et al., 2005; Viswanathan, et al., 2009; Polesskaya 
et al., 2007) and it also helps to establish pluripotency in iPS cells (Yu et al., 2007). 
However, various studies showed that its knockdown does not cause differentiation of ES 
cells (Xu and Huang, 2009; Viswanathan et al., 2008; Darr and Benvenisty, 2008; Balzer 
et al., 2010). In our knockdown experiments, using either siRNA or shRNA, the transcript 
levels of none of the pluripotency or differentiation markers has changed significantly. It 
should be noted that knockdown or overexpression of Lin28 in mouse ES cells resulted in 
compromised or enhanced cell cycle progression respectively (Xu and Huang, 2009; Xu et 
al., 2009), whereas such change was not observed when Lin28 expression was modulated 
in mouse EC cells (Balzer et al., 2010). Through these observations, we conclude that 
although LIN28 may contribute to the proliferation of ES cells, it is not indispensable in 
the maintenance of self-renewal in ES cells. 
Under the induction of differentiation, mouse ES cells (R1) with repressed Lin28 
expression showed decrease of Oct4 and Nanog mRNA expression compared to siGFP 
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control, (Heo et al., 2009). Two other studies through the directed differentiation of Lin28 
overexpression stable lines discovered its roles in neuronal or germ cell differentiation 
respectively (Balzer et al., 2010; West et al., 2009). These results suggest that Lin28 is 
involved in the cell fate decision during differentiation. 
 
4.2.4 LIN28 is an essential factor in post-transcriptional regulation 
 
Gene expression is initiated from transcription and continues to post-transcriptional 
RNA regulation, including 5’ cap addition, RNA splicing, polyadenylation, export, 
stabilization, decay and translation, which has been recognized as a key mechanism in 
controlling gene expression during important biological process such as stress response 
and cancer genesis (Audic and Hartley, 2004; Holland et al., 2004). Recent advances in 
RNA biology revealed unexpected diversity and complexity of post-transcriptional RNA 
metabolism and it was stressed that all these regulatory steps are seamlessly interconnected 
(Kim et al., 2009b). RNA binding proteins (RBPs) are essential players in RNA post-
transcriptional regulation. Their importance is reflected by the fact that RNAs cannot exist 
alone in cells, but are stably assembled with many RBPs and other proteins, which exist as 
ribonucleoprotein particles (RNPs). 
As an RNA binding protein, LIN28, unlike the other reprogramming factors OCT4, 
NANOG, SOX2, MYC and KLF4, does not play a direct role in regulating transcription 
but instead is important for post-transcriptional regulation. Several previous studies in 
mouse ES cells showed that modulation of LIN28 expression does not cause drastic 
changes in expression of target genes. When Lin28 protein level was reduced to 24%, the 
levels of cyclin A, cyclin B, and cdk4 proteins were decreaced to 37%, 35% and 44%, 
respectively. However, in replicated experiments, they did not observe significant change 
in the levels of their corresponding mRNAs (Xu et al., 2009). Another study showed that 
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when mouse ES cells were transfected with a vector that overexpressed Flag-tagged Lin28, 
mRNAs of Histone H2a were enriched to the RNPs isolated by anti-Flag antibody, but the 
overall level of Histone H2a mRNA in the cell extract was not changed significantly (Xu 
and Huang, 2009). Plenty of evidence also demonstrated that Lin28 regulates maturation of 
miRNAs but not their transcription (Viswanathan et al., 2008; Heo et al., 2008; Rybak et 
al., 2008; Piskounova et al., 2008 ; Heo et al., 2009).  
DNA microarray has been used to explore the function of RBPs after depletion (Huot 
et al., 2005; Busà et al., 2007; Jeng et al., 2008), but to date, no LIN28 knockdown or 
LIN28 knockout cells have been analyzed by DNA microarray. In this current work, as 
expected, the number of genes that are modulated by each type of knockdown is not large 
and the changes in level of transcripts are small but can be measured by DNA microarray. 
Also the majority of the differentially expressed mRNAs in the LIN28 knockdown NCCIT 
cells might be either due to molecular stabilization or degradation in a LIN28-binding 
dependent manner, or due to the downstream consequences of altered levels of proteins 
regulated by LIN28. 
 
4.2.5 LIN28 regulates other RNA post-transcriptional regulators 
 
Transcriptional control of ES cells has been intensively studied, but their post-
transcriptional control has remained largely unknown. Transcriptome studies have stressed 
the importance of RBPs and post-transcriptional regulation in human ES cells, where both 
shortSAGE and longSAGE data revealed that human ES cells expressed proportionately 
more RBPs compared with terminally differentiated cells (Richards, et al., 2004; Hirst et 
al., 2007). Recently, Sampath and colleagues (2008) showed parsimonious translation in 
pluripotent state and hierarchical translational regulation during differentiation by global 
assessment of ribosome loading for mouse ES cells and EBs. This also underscores the 
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importance of translation and other related upstream post-transcriptional regulation in 
pluripotency and differentiation in ES cells. 
After LIN28 knockdown, we found that LIN28 regulates a group of genes, which 
play various roles in different post-transcriptional regulatory steps. RBM39, SRRM1, 
PRPF38A and MYB are involved in pre-mRNA splicing, which is important for the 
subsequent mRNA export, subcellular localization and translation. PRPF38A associates 
with the spliceosomal B complex, the substrate that undergoes catalytic activation leading 
to catalysis of pre-mRNA splicing (Deckert et al., 2006). A well-known haematopoietic 
transcription factor, MYB was also affected by LIN28 knockdown, which was reported to 
affect 5’-splice site selection step recently, suggesting that MYB might serve a previously 
unappreciated role in the coupling between transcription and splicing (Orvain et al., 2008).  
It has been proposed that the key export mediator THO/TREX complex, which is 
positioned at the 5’ end of spliced mRNAs, imparts directionality to ensure that the 5’ end 
of the RNA transcripts emerging from the nuclear pore are immediately engaged by the 
translation machinery (Valencia et al., 2008). After being exported to the cytoplasm, 
spliced mRNAs yield more protein molecules than identical unspliced transcripts and are 
engaged by the translation machinery better during the pioneer round of translation (Le Hir 
et al., 2003). Another mechanism linking RNA splicing and other downstream post-
transcriptional processes involves the exon junction complex (EJC). Intriguingly, SRRM1 
is one of the key components in EJC and it is identified in our results. EJC stably binds to 
the spliced mRNA about 20 nucleotides upstream of exon-exon junctions and companies 
the mRNA to the cytoplasm (Lejeune, 2002). EJC is also reported to recruit 48S 
preinitiation complex or 40S ribosomal protein S6 kinase 1 (S6K1), a central player in 
TOR pathway, which enhances translation initiation (Diem et al., 2007; Ma et al., 2008). 
Additionally, EJC plays an important role in nonsense-mediated mRNA decay (NMD), a 
major translation-dependent degradation pathway (Stalder and Muhlemann, 2008). 
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Cytoplasmic polyadenylation might be another post-transcriptional regulation 
regulated by LIN28. CPEB1, which encodes one of the cytoplasmic polyadenylation 
element (CPE)-binding proteins, was found up-regulated after Lin28 knockdown, key 
regulators to control the length of poly(A) tail in cytoplasm. It is known that initiation of 
translation is the rate-limiting step, where the 5’ cap and the 3’ poly(A) tail are brought 
into close proximity by protein bridge and the length of poly(A) is an important factor here. 
Cytoplasmic polyadenylation is one mechanism that regulates early animal development 
(Huarte et al., 1992; Richter, 2000; Kim and Richter, 2006). In Xenopus oocytes, CPEB is 
able to recruit both cytoplasmic poly(A) polymerase (GLD2) and poly(A) ribonuclease 
(PARN) to the cis-acting polyadenylation element in the 3’ UTR of target transcripts, so 
that the poly(A) is dynamically regulated (Kim and Richter, 2006). CPEB-modulated 
cytoplamic polyadenylation has also been found to perform essential roles in neuronal 
synaptic plasticity and cellular senescence (Richter, 2007; Burns and Richter, 2008). 
Another mechanism involving CPEB has been proposed, in which translation of mRNAs 
containing a CPE is repressed by displacement of eIF4G by Maskin/4E-T, recruited by 
CPEB (Sonenberg and Hinnebusch, 2009). It is also known that shortened poly(A) tail is 
vulnerable to mRNA degradation (Houseley and Tollervey, 2009). Whether CPEB’s 
regulation on poly(A) length is connected to degradation pathway is worth investigation. 
CSDE plays roles in multiple steps of post-transcriptional regulation. It contains five 
cold-shock domains (CSD), which is also the active domain in LIN28 protein. CSD is a 
domain with ~70 amino acid residues, which is highly conserved during evolution and 
binds single strand DNA and RNA. CSDE is involved in mRNA degradation, mRNA 
stabilization and repression of translation (Grosset et al., 2000; Dinur et al., 2006; Duncan 
et al., 2006). Its function in mouse ES cells and the human somatic hepatoma cell line 
HuH7 has been reported. The Csde-deficient mouse ES cells showed decreased sensitivity 
to ionizing radiation (IR) - induced apoptosis, while on the contrary in HuH7, siRNA-
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induced CSDE knockdown resulted in apoptosis induction (Dormoy-Raclet et al., 2007). It 
may also regulate biological processes like apoptosis through post-transcriptional 
regulation on key genes in human ES cells.  
There are many other post-transcriptional regulatory steps affected by LIN28 
knockdown. ZMAT3 with dsRNA-binding activity has been proven to associate with Dicer 
and to promote its dsRNase activity (Méndez et al., 2006). Therefore, it might be involved 
in microRNA processing and subsequent microRNA-mediated post-transcriptional 
regulation. Another RBP, ZNF74, shows specific binding affinity to poly(G) and poly(U) 
(Grondin et al., 1996), and interestingly, the addition of poly(U) tail could trigger RNA 
degradation (Mullen and Marzluff, 2008). The addition of poly(U) is also involved in 
Lin28-mediated let-7 microRNA repression, and yet the detailed mechanism has not been 
elucidated (Hagan et al., 2009; Heo et al., 2009). The rest genes are related to rRNA 
(NPM3 and PTRF), tRNA (GTPBP3 and TSEN34) and ribosomal protein (MRPL11) 
metabolism, all of which are essential components of translation machinery (Huang et al., 
2005; Jansa et al., 1998; Paushkin et al., 2004; Orvain et al., 2008; Voronina et al., 2003).  
Taken together, LIN28 might act as a master regulator of pluripotency and 
differentiation in human ES cells either by directly modulating genes such as POU5F1, 
Histone H2a and cell cycle regulators, which are responsible for pluripotency, or by 
modulating other post-transcriptional regulators including let-7 microarray family to form 
a hierarchical post-transcriptional control.  
 
4.2.6 Inducible NCCIT LIN28sh stable line can be a good tool for 
embryonic development study 
 
Lentiviral transduction of human ES cells has been successfully demonstrated 
(Zaehres et al., 2005; Xiong et al., 2005; Rodriguez et al., 2007; Fu et al., 2008; Unger et 
al., 2008; Jiang et al., 2010). The transduction efficiency varied a lot. In one such study, 
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the efficiency of lentiviral transduction, with MOI of 5, 10 and 20, were investigated using 
H1 cell line and the highest efficiency of 72% was achieved at an MOI of 20 (Xiong et al., 
2005). There were two reports that showed lower efficiency of 50% at an MOI of 50 and 
20-30% at an MOI of >10 (Zaehres et al., 2005; Unger et al., 2008). Jiang et al. (2010) 
reported that at an MOI of 50, nearly 10% H1 cells were transduced, whereas less than 2% 
cells were transduced at an MOI of 10. However, in our study, using an MOI of 5, we did 
not succeed in transducing HES3 cells. 
We have however managed to generate an inducible LIN28sh stable line from human 
EC cell line NCCIT. Like ES cells, EC cells also showed extensive capability of self-
renewal and the potential to differentiate into cell types in all three germ layers (Andrews 
et al., 1984). Resemblance to ES cells and resistance to spontaneous differentiation among 
other advantages makes EC cells a good alternative to study certain aspects of pluripotency 
and embryonic development (Josephson et al., 2007). For example, the functions of many 
pluripotency genes including LIN28, OCT4 and NANOG have been studied using human 
EC cells as a model. (Peng et al., 2010; Lim et al., 2009; You et al., 2009) 
As discussed in section 4.2.1, transient transfection using cationic lipid-based method 
will bring irrelevant effects such as membrane rupture and charge neutralization during 
endocytosis to the cells, which can be circumvented by the LIN28sh stable line 
successfully. Stable knockdown of LIN28 is better than transient knockdown in studying 
protein levels of its targets, since LIN28 is a post-transcriptional regulator. Stable line is 
also more suitable for experiments with longer time frame. For example, two studies have 
subjected mouse EC or ES cells overexpressing Lin28 to direct differentiation towards 
specific lineages and investigated its role in cell fate decision during differentiation (West 
et al., 2009; Balzer et al., 2010). Human ES cell line, H9 has been used to establish a stable 
line that constitutively overexpresses LIN28. Continuous expression of LIN28 caused 
increase of differentiation to extra-embryonic endoderm and a slower cell cycle (Darr and 
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Benvenisy, 2008). Compared to the constitutive stable line, our NCCIT LIN28sh stable 
line was demonstrated to be inducible in the presence of DOX and the knockdown of 
LIN28 was correlated with the intensity of EGFP expression, which made the monitoring 
of LIN28 knockdown easier. Especially, the inducibility is critical to study the function of 
LIN28, because the timing is important for LIN28 to perform its role during development. 
For instance, Lin28 has been shown to control the succession of cell fates during tissue 
development (Balzer et al., 2010). As the establishment of protocols for direct 
differentiation of pluripotent cells towards desired cell lineages, inducible NCCIT LIN28sh 
stable line can be a more potent tool to study the LIN28’s role in various events during 
differentiation. 
 
4.3 Conclusions and future work 
4.3.1 Conclusions 
 
We hypothesize that the genes responsible for the maintenance of pluripotency 
would share a common expression pattern in undifferentiated human ES cells when 
compared to their differentiated counterparts or other tissue types. In HCA analysis, human 
ES and EC cells shared a major gene cluster containing the majority of the pluripotency 
markers. Within NANOG, POU5F1/LIN28 and SOX2 sub-clusters, in addition to many 
well-known pluripotency markers, we have also identified other genes such as PERP, 
BAMBI and SALL2, which are potential pluripotency regulators or are transcriptionally 
regulated by them. Many EST and orphan SAGE tags were also identified and these should 
represent novel transcripts. To explore the expression patterns of human ES cells (HES3) 
upon differentiation, a Transchisq clustering method was used. Different expression 
patterns were identified, including differentiation, pluripotency, shortSAGE-specific, 
longSAGE-specific and longSAGE UD-specific patterns. The majority of the patterns 
could be validated by qRT-PCR profiling using a series of EBs at different temporal stages. 
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Based on both the SAGE data and experimental qRT-PCR data, we proposed TERF1, 
SOX2, C14ORF115, NANOG and LIN28 could be the good pluripotency markers and 
differentiation markers such as DCN, AA853630 and APOC3 could serve better to assess 
the true state of the pluripotent cells, due to their earlier and higher fold change in 
expression upon differentiation of human ES cells. 
To study the biological function of LIN28 in pluripotency, we carried out siRNA and 
shRNA mediated knockdown of LIN28 in human EC cell line. Based on results from us 
and other studies, we conclude that LIN28 is not indispensable in self-renewal of 
pluripotent cells but plays important roles in cell fate decision during differentiation. 
Various aspects of post-transcriptional regulation such as mRNA splicing, cytoplasmic 
polyadenylation, and mRNA stabilization were shown to be regulated by LIN28. In 
conclusion, we propose that LIN28 might act as a master regulator in differentiation and 
establishment of pluripotency by directly modulating genes responsible for pluripotency or 
by modulating other post-transcriptional regulators to form a hierarchical post-
transcriptional control. 
 
4.3.2 Future work 
 
To better understand the mechanism of how pluripotency is maintained, more genes 
responsible for pluripotency need to be identified and studied. In this work, we found many 
novel pluripotency and differentiation genes such as C14ORF115 and DCN. Their exact 
roles in self-renewal and lineage potential have yet to be investigated. We have also found 
orphan SAGE tags and ESTs that show unique expression in human ES/EC cells, which 
could represent novel transcripts. Obtaining their full length is essential for their functional 
study, where reverse SAGE and Rapid Amplification of cDNA Ends (RACE) could be 
useful tools (Yu et al., 1999; Ohara et al., 1989; Frohman et al., 1988). 
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To understand how LIN28 forms the hierarchical control in post-transcriptional 
regulation, global RNA binding of LIN28 needs to be characterized in different tissues and 
development stages. This is feasible as the improvement in protocol for 
immunoprecipitation of RNA-protein complexes (Zeng et al., 2006; Zielinski et al., 2006; 
Peritz et al., 2006; Barkan, 2009; Huber and Zhao, 2010). After LIN28-containing RNPs 
are precipitated, primers specific to the target mRNAs regulated by LIN28 which we 
identified in this study can be used to explore the mRNA-protein interactions. 
Alternatively, immunoprecipitation of RNPs can be combined with cDNA microarrays 
(Tenenbaum et al., 2002; Barkan, 2009) or Illumina sequencing platform (Johnson et al., 
2007; Mikkelsen et al., 2007) for a more universal screening of LIN28-interacting RNAs. 
Since LIN28 itself doesn’t have enzyme activity and it has been proven to be able to 
recruits other enzymes such as eIF3b, RHA and TUTase4 (Polesskaya et al., 2007; Heo et 
al., 2009; Hagan et al., 2009; Qiu et al., 2010), a yeast two-hybrid system could be useful 
to screen candidate proteins interacting with LIN28 to exert their functions in different 
post-transcriptional regulatory steps. 
We have generated an inducible LIN28sh NCCIT stable line. As we mentioned 
before, the knockdown efficiency is important for the study of LIN28’s function. Thus, 
generation of a homogeneous stable line from single cell is essential. The inducible 
LIN28sh stable line should be utilized to study the role of LIN28 during differentiation of 
human EC cells or the precursor cells derived from them. 
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